Fachzeitschriften

Stand: 23.2.2017

(Abkürzungen: * =authors have contributed equally)

Zitierungen, h-index: siehe Google Scholar

458 Kowalski ML, Ansotegui I, Aberer W, Al-Ahmad M, Akdis M, Ballmer-Weber BK, Beyer K, Blanca M, Brown S, Bunnag C, Hulett AC, Castells M, Chng HH, De Blay F, Ebisawa M, Fineman S, Golden DB, Haahtela T, Kaliner M, Katelaris C, Lee BW, Makowska J, Muller U, Mullol J, Oppenheimer J, Park HS, Parkerson J, Passalacqua G, Pawankar R, Renz H, Rueff F, Sanchez-Borges M, Sastre J, Scadding F, Sicherer S, Tantilipikorn P, Tracy J, van Kampen V, Bohle B, Canoncia GW, Caraballo L, Gomez M, Ito K, Jensen-Jarolim E, Larche M, Melioli G, Poulsen LK, Valenta R, Zuberbier T: Erratum to: Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement. WAO Journal 2017; 10(1): 6.
457 Anto JM, Bousquet J, Akdis M, Auffray C, Keil T, Momas I, Postma DS, Valenta R, Wickman M, Cambon-Thomsen A, Haahtela T, Lambrecht BN, Lodrup Carlsen KC, Koppelman GH, Sunyer J, Zuberbier T, Annesi-Maesano I, Arno A, Bindslev-Jensen C, De Carlo G, Forastiere F, Heinrich J, Kowalski ML, Maier D, Melén E, Smit HA, Stnadl M, Wright J, Asarnoj A, Benet M, Ballardini N, Garcia-Aymerich J, Gehring U, Guerra S, Hohmann C, Kull I, Lupinek M, Pinart M, Skrindo I, Westman M, Smagghe D, Akdis C, Andersson N, Bacher C, Ballereau S, Ballester F, Basagana X, Bedbrook A, Bergstrom A, von Berg A, Brunekreef B, Burte E, Carlsen KH, Chatzi L, Coquet JM, Curin M, Demoly P, Eller E, Fantini MP, von Hertzen L, Hovland V, Jacquemin B, Just J, Keller T, Kiss R, Kogevinas M, Koletzko S, Lau S, Lehmann I, Lemonnier N, Mäkelä M, Mestres J, Mowinckel P, Nadif R, Nawijn MC, Pellet J, Pin I, Porta D, Rancière F, Rial-Sebbag, E, Saeys Y, Schuijs MJ, Siroux V, Tischer CG, Torrent M, Varraso R, Wenzel K, Xu CJ: Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes. J Allergy Clin Immunol 2017; 139(2):388-399.
456 Zuberbier T, Dörr T: Allergologie. Aktuelle Dermatologie; 01/02(43): 17-20.
455 Bergmann KC. Sehlinger T, Gildemeister J, Zuberbier T: A novel experimental technology for testing efficacy of air purifiers on pollen reduction. Allergo J Int 2017; 26(1): 20-25.
454 Bousquet J, Agache I, Anto JM, Bergmann C, Claus Bachert C, Annesi‐Maesano I, Bousquet PJ, D'Amato G, Demoly P, De Vries G, Eller E, Fokkens W, Fonseca J, Haahtela T, Hellings PW, Just J, Keil T, Klimek L, Kuna P, Lodrup Carlsen KC, Mösges R, Murray R, Nekam K, Onorato G, Papadopoulos NG, Samolinski B, Schmid‐Grendelmeier P, Thibaudon M, Tomazic P, Triggiani M, Valiulis A, Valovirta E, Eerd MV, Wickman M, Zuberbier T, Sheikh A: Google Trends terms reporting rhinitis and related topics differ in European countries. Allergy 2017; doi: 10.1111/all.13137. [Epub ahead of print]
453 Pfaar O, Calderon MA, Andrews CP, Angjeli E, Bergmann KC, Bønløkke JH, de Blay F, Devillier P, Ellis AK, Gerth van Wijk R, Hohlfeld J, Horak F, Jutel M, Jacobs RL, Jacobsen L, Kaul S, Larché M, Larenas-Linnemann D, Mösges R, Nolte H, Patel P, Peoples L, Rabin RL, Rather C, Salapatek AM, Sigsgaard T, Thaarup S, Yang J, Zieglmayer P, Zuberbier T, Demoly P: Allergen Exposure Chambers (AEC): harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper. Allergy 2017; doi: 10.1111/all.13133.
452 Bousquet J, Caimmi DP, Bedbrook A, Bewick M, Hellings PW, Devillier P, Arnavielhe S, Bachert C, Bergmann KC, Canonica GW, Chavannes N, Cruz AA, Dahl R, Demoly P, De Vries G, Mathieu-Dupas E, Fink Wagner A, Fonseca J, Guldemond N, Haahtela T, Hellqvist-Dahl B, Just J, Keil T, Klimek L, Kowalski ML, Kuitunen M, Kuna P, Kvedariene V, Laune D, Pereira AM, Carreiro-Martins P, Melén E, Morais-Almeida M, Mullol J, Muraro A, Murray R, Nogueira-Silva L, Papadopoulos NG, Passalacqua G, Portejoie F, Price D, Ryan D, Samolinski B, Sheikh A, Siroux V, Spranger O, Bom AT, Tomazic PV, Valero A, Valovirta E, Valiulis A, VandenPlas O, van der Meulen S, van Eerd M, Wickman M, Zuberbier T: Pilot study of mobile phone technology in allergic rhinitis in European countries. The MASK-rhinitis study. Allergy 2017; doi: 10.1111/all.13125. [Epub ahead of print].
451 Barmeyer C, Schumann M, Meyer T, Zielinski C, Zuberbier T, Siegmund B, Schulzke J-D, Daum S, Ullrich R: Long-term response to gluten-free diet as evidence for non-celiac wheat sensitivity in one third of patients with diarrhea-dominant and mixed-type irritable bowel syndrome; Int J Colorectal Dis 2017: 32(1): 29-39.
450 Bousquet J, Bewick M, Cano A, Eklund P, Fico G, Goswami N, Guldemond NA, Henderson D, Hinkema MJ, Liotta G, Mair A, Molloy W, Monaco A, Monsonis-Paya I, Nizinska A, Papadopoulos H, Pavlickova A, Pecorelli S, Prados-Torres A, Roller-Wirnsberger RE, Somekh D, Vera-Muñoz C, Visser F, Farrell J, Malva J, Andersen Ranberg K, Camuzat T, Carriazo AM, Crooks G, Gutter Z, Iaccarino G, Manuel de Keenoy E, Moda G, Rodriguez-Mañas L, Vontetsianos T, Abreu C, Alonso J, Alonso-Bouzon C, Ankri J, Arredondo MT, Avolio F, Bedbrook A, Białoszewski AZ, Blain H, Bourret R, Cabrera-Umpierrez MF, Catala A, O'Caoimh R, Cesari M, Chavannes NH, Correia-da-Sousa J, Dedeu T, Ferrando M, Ferri M, Fokkens WJ, Garcia-Lizana F, Guérin O, Hellings PW, Haahtela T, Illario M, Inzerilli MC, Lodrup Carlsen KC, Kardas P, Keil T, Maggio M, Mendez-Zorrilla A, Menditto E, Mercier J, Michel JP, Murray R, Nogues M, O'Byrne-Maguire I, Pappa D, Parent AS, Pastorino M, Robalo-Cordeiro C, Samolinski B, Siciliano P, Teixeira AM, Tsartara SI, Valiulis A, Vandenplas O, Vasankari T, Vellas B, Vollenbroek-Hutten M, Wickman M, Yorgancioglu A, Zuberbier T, Barbagallo M, Canonica GW, Klimek L, Maggi S, Aberer W, Akdis C, Adcock IM, Agache I, Albera C, Alonso-Trujillo F, Angel Guarcia M, Annesi-Maesano I, Apostolo J, Arshad SH, Attalin V, Avignon A, Bachert C, Baroni I, Bel E, Benson M, Bescos C, Blasi F, Barbara C, Bergmann KC, Bernard PL, Bonini S, Bousquet PJ, Branchini B, Brightling CE, Bruguière V, Bunu C, Bush A, Caimmi DP, Calderon MA, Canovas G, Cardona V, Carlsen KH, Cesario A, Chkhartishvili E, Chiron R, Chivato T, Chung KF, d'Angelantonio M, De Carlo G, Cholley D, Chorin F, Combe B, Compas B, Costa DJ, Costa E, Coste O, Coupet AL, Crepaldi G, Custovic A, Dahl R, Dahlen SE, Demoly P, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Du Toit G, Dubakiene R, Dupeyron A, Emuzyte R, Fiocchi A, Wagner A, Fletcher M, Fonseca J, Fougère B, Gamkrelidze A, Garces G, Garcia-Aymeric J, Garcia-Zapirain B, Gemicioğlu B, Gouder C, Hellquist-Dahl B, Hermosilla-Gimeno I, Héve D, Holland C, Humbert M, Hyland M, Johnston SL, Just J, Jutel M, Kaidashev IP, Khaitov M, Kalayci O, Kalyoncu AF, Keijser W, Kerstjens H, Knezović J, Kowalski M, Koppelman GH, Kotska T, Kovac M, Kull I, Kuna P, Kvedariene V, Lepore V, MacNee W, Maggio M, Magnan A, Majer I, Manning P, Marcucci M, Marti T, Masoli M, Melen E, Miculinic N, Mihaltan F, Milenkovic B, Millot-Keurinck J, Mlinarić H, Momas I, Montefort S, Morais-Almeida M, Moreno-Casbas T, Mösges R, Mullol J, Nadif R, Nalin M, Navarro-Pardo E, Nekam K, Ninot G, Paccard D, Pais S, Palummeri E, Panzner P, Papadopoulos NK, Papanikolaou C, Passalacqua G, Pastor E, Perrot M, Plavec D, Popov TA, Postma DS, Price D, Raffort N, Reuzeau JC, Robine JM, Rodenas F, Robusto F, Roche N, Romano A, Romano V, Rosado-Pinto J, Roubille F, Ruiz F, Ryan D, Salcedo T, Schmid-Grendelmeier P, Schulz H, Schunemann HJ, Serrano E, Sheikh A, Shields M, Siafakas N, Scichilone N, Siciliano P, Skrindo I, Smit HA, Sourdet S, Sousa-Costa E, Spranger O, Sooronbaev T, Sruk V, Sterk PJ, Todo-Bom A, Touchon J, Tramontano D, Triggiani M, Tsartara SI, Valero AL, Valovirta E, van Ganse E, van Hage M, van den Berge M, Vandenplas O, Ventura MT, Vergara I, Vezzani G, Vidal D, Viegi G, Wagemann M, Whalley B, Wickman M, Wilson N, Yiallouros PK, Žagar M, Zaidi A, Zidarn M, Hoogerwerf EJ, Usero J, Zuffada R, Senn A, de Oliveira-Alves B: Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA. J Nutr Health Aging 2017; 21(1):92-104.
449 Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, Bewick M, Bindslev-Jensen C, Bosnic-Anticevitch S, Bucca C, Caimmi DP, Camargos PA, Canonica GW, Casale T, Chavannes NH, Cruz AA, De Carlo G, Dahl R, Demoly P, Devillier P, Fonseca J, Fokkens WJ, Guldemond NA, Haahtela T, Illario M, Just J, Keil T, Klimek L, Kuna P, Larenas-Linnemann D, Morais-Almeida M, Mullol J, Murray R, Naclerio R, O'Hehir RE, Papadopoulos NG, Pawankar R, Potter P, Ryan D, Samolinski B, Schunemann HJ, Sheikh A, Simons FE, Stellato C, Todo-Bom A, Tomazic PV, Valiulis A, Valovirta E, Ventura MT, Wickman M, Young I, Yorgancioglu A, Zuberbier T, Aberer W, Akdis CA, Akdis M, Annesi-Maesano I, Ankri J, Ansotegui IJ, Anto JM, Arnavielhe S, Asarnoj A, Arshad H, Avolio F, Baiardini I, Barbara C, Barbagallo M, Bateman ED, Beghé B, Bel EH, Bennoor KS, Benson M, Białoszewski AZ, Bieber T, Bjermer L, Blain H, Blasi F, Boner AL, Bonini M, Bonini S, Bosse I, Bouchard J, Boulet LP, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Bunu C, Burte E, Bush A, Caballero-Fonseca F, Calderon MA, Camuzat T, Cardona V, Carreiro-Martins P, Carriazo AM, Carlsen KH, Carr W, Cepeda Sarabia AM, Cesari M, Chatzi L, Chiron R, Chivato T, Chkhartishvili E, Chuchalin AG, Chung KF, Ciprandi G, de Sousa JC, Cox L, Crooks G, Custovic A, Dahlen SE, Darsow U, Dedeu T, Deleanu D, Denburg JA, De Vries G, Didier A, Dinh-Xuan AT, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Du Toit G, Dykewicz MS, Eklund P, El-Gamal Y, Ellers E, Emuzyte R, Farrell J, Fink Wagner A, Fiocchi A, Fletcher M, Forastiere F, Gaga M, Gamkrelidze A, Gemicioğlu B, Gereda JE, van Wick RG, González Diaz S, Grisle I, Grouse L, Gutter Z, Guzmán MA, Hellquist-Dahl B, Heinrich J, Horak F, Hourihane JO, Humbert M, Hyland M, Iaccarino G, Jares EJ, Jeandel C, Johnston SL, Joos G, Jonquet O, Jung KS, Jutel M, Kaidashev I, Khaitov M, Kalayci O, Kalyoncu AF, Kardas P, Keith PK, Kerkhof M, Kerstjens HA, Khaltaev N, Kogevinas M, Kolek V, Koppelman GH, Kowalski ML, Kuitunen M, Kull I, Kvedariene V, Lambrecht B, Lau S, Laune D, Le LT, Lieberman P, Lipworth B, Li J, Lodrup Carlsen KC, Louis R, Lupinek C, MacNee W, Magar Y, Magnan A, Mahboub B, Maier D, Majer I, Malva J, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Mathieu-Dupas E, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Mercier J, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Millot-Keurinck J, Mohammad Y, Momas I, Mösges R, Muraro A, Namazova-Baranova L, Nadif R, Neffen H, Nekam K, Nieto A, Niggemann B, Nogueira-Silva L, Nogues M, Nyembue TD, Ohta K, Okamoto Y, Okubo K, Olive-Elias M, Ouedraogo S, Paggiaro P, Pali-Schöll I, Palkonen S, Panzner P, Papi A, Park HS, Passalacqua G, Pedersen S, Pereira AM, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov TA, Portejoie F, Postma D, Poulsen LK, Price D, Rabe KF, Raciborski F, Roberts G, Robalo-Cordeiro C, Rodenas F, Rodriguez-Mañas L, Rolland C, Roman Rodriguez M, Romano A, Rosado-Pinto J, Rosario N, Rottem M, Sanchez-Borges M, Sastre-Dominguez J, Scadding GK, Scichilone N, Schmid-Grendelmeier P, Serrano E, Shields M, Siroux V, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Sterk PJ, Strandberg T, Sunyer J, Thijs C, Triggiani M, Valenta R, Valero A, van Eerd M, van Ganse E, van Hague M, Vandenplas O, Varona LL, Vellas B, Vezzani G, Vazankari T, Viegi G, Vontetsianos T, Wagenmann M, Walker S, Wang DY, Wahn U, Werfel T, Whalley B, Williams DM, Williams S, Wilson N, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zaidi A, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M: ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy 2016; 6: 47.
448 Calderon MA, Demoly P, Casale T, Akdis CA, Bachert C, Bewick M, Bilò BM, Bohle B, Bonini S, Bush A, Caimmi DP, Canonica GW, Cardona V, Chiriac AM, Cox L, Custovic A, De Blay F, Deviliier P, Didier A, Di Lorenzo G, Du Toit G, Durham SR, Eng P, Fiocchi A, Fox AT, van Wijk RG, Gomez RM, Haathela T, Halken S, Hellings PW, Jacobsen L, Just J, Tanno LK, Kleine-Tebbe J, Klimek L, Knol EF, Kuna P, Larenas-Linnemann DE, Linneberg A, Matricardi M, Malling HJ, Moesges R, Mullol J, Muraro A, Papadopoulos N, Passalacqua G, Pastorello E, Pfarr O, Price D, Del Rio PR, Ruëff R, Samolinski B, Scadding GK, Senti G, Shamji MH, Sheikh A, Sisul JC, Sole D, Sturm GJ, Tabar A, Van Ree R, Ventura MT, Vidal C, Varga EM, Worm M, Zuberbier T, Bousquet J: Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing ) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project. Clin Transl Allergy 2016; 6: 41.
447 Braido F, Scichilone N, Lavorini F, Usmani OS, Dubuske L, Boulet LP, Mosges R, Nunes C, Sanchez-Borges M, Ansotegui IJ, Ebisawa M, Levi-Schaffer F, Rosenwasser LJ, Bousquet J, Zuberbier T, Canonica GW, Cruz A, Yanez A, Yorgancioglu A, Delenau D, Rodrigo G, Berstein J, Ohta K, Vichyanond P, Pawankar R, Gonzalez-Diaz SN, Nakajima S, Slavyanskaya T, Fink-Wagner A, Loyola CB, Ryan D, Passalacqua G, Celedon J, Ivancevich JC, Dobashi K, Zernotti M, Akdis M, Benjaponpitak S, Bonini S, Burks W, Caraballo L, El-Sayed ZA, Fineman S, Greenberger P, Hossny E, Ortega-Martell JA, Saito H, Tang M, Zhang L; for Interasma Executive Board; ARIA; GA2LEN: Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Netword (GA(2)LEN). WAO Journal 2016; 9(1): 37.
446 Kowalski ML, Ansotegui I, Aberer W, Al-Ahmad M, Akdis M, Ballmer-Weber BK, Beyer K, Blanca M, Brown S, Bunnag C, Hulett AC, Castells M, Chng HH, De Blay F, Ebisawa M, Fineman S, Golden DB, Haahtela T, Kaliner M, Katelaris C, Lee BW, Makowska J, Muller U, Mullol J, Oppenheimer J, Park HS, Parkerson J, Passalacqua G, Pawankar R, Renz H, Rueff F, Sanchez-Borges M, Sastre J, Scadding G, Sicherer S, Tantilipikorn P, Tracy J, van Kempen V, Bohle B, Canonica GW, Caraballo L, Gomez M, Ito K, Jensen-Jarolim E, Larche M, Melioli G, Poulsen LK, Valenta R, Zuberbier T: Risk and safety requirements for diagnostic and therapeuti procedures in allergology: Word Allergy Organization Statement. WAO Journal 2016; 9(1): 33.
445 Babina M, Guhl S, Artuc M, Zuberbier T: Skin mast cell phenotypes between two highly divergent cohorts - more pronounced variability within than between groups. Exp Dermatol 2016; doi:10.1111/exd.13227 [Epub ahead of print].
444 Babina M, Guhl S, Artuc M, Zuberbier T: IL-4 and human skin mast cells revisited: reinforcement of a pro-allergic phenotype upon prolonged exposure. Arch Dermatol Res 2016; 308(9): 665-670.
443 Bousquet J, Farrell J, Crooks G, Hellings P, Bel EH, Bewick M, Chavannes NH, de Sousa JC, Cruz AA, Haahtela T, Joos G, Khaltaev N, Malva J, Muraro A, Nogues M, Palkonen S, Pedersen S, Robalo-Cordeiro C, Samolinski B, Strandberg T, Valiulis A, Yorgancioglu A, Zuberbier T, Bedbrook A, Aberer W, Adachi M, Agusti A, Akdis CA, Akdis M, Ankri J, Alonso A, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arnavielhe S, Arshad H, Bai C, Baiardini I, Bachert C, Baigenzhin AK, Barbara C, Bateman ED, Beghé B, Kheder AB, Bennoor KS, Benson M, Bergmann KC, Bieter T, Bindslev-Jensen C, Bjermer L, Blain H, Blasi F, Boner AL, Bonini M, Bonini S, Bosnic-Anticevitch S, Boulet LP, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Burney PG, Bush A, Caballero-Fonseca F, Caimmi D, Calderon MA, Calverley PM, Camargos PA, Cononica GW, Camuzat T, Carlsen KH, Carr W, Carriazo A, Casale T, Cepeda Sarabia AM, Chatzi L, Chen YZ, Chiron R, Chkhartishvili E, Chuchalin AG, Chung KF, Ciprandi G, Cirule I, Cox L, Costa DJ, Custovic A, Dahl R, Dahlen SE, Darsow U, De Carlo G, De Blay F, Dedeu T, Deleanu D, De Manuel Keenoy E, Demoly P, Denburg JA, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, Emuzyte R, Fabbri LM, Fletcher M, Fiocchi A, Fink Wagner A, Fonseca J, Fokkens WJ, Forastiere F, Frith P, Gaga M, Gamkrelidze A, Garces J, Garcia-Aymerich J, Gemicioglu B, Gereda JE, González Diaz S, Gotua M, Grisle I, Grouse L, Gutter Z, Guzmán MA, Heaney LG, Hellquist-Dahl B, Henderson D, Hendry A, Heinrich J, Heve D, Horak F, Hourihane JO, Humbert M, Hyland ME, Illario M, Ivancevich JC, Jardim JR, Jares EJ, Jeandel C, Jenkins C, Johnston SL, Jonquet O, Julge K, Jung KS, Just J, Kaidashev I, Kaitov MR, Kalayci O, Kalyoncu AF, Keil T, Keith PK, Klimek L, Koffi N'Goran B, Kolek V, Koppelman GH, Kowalski ML, Kull I, Kuna P, Kvedariene V, Lambrecht B, Lau S, Larenas-Linnemann D, Laune D, Le LT, Lieberman P, Lipworth B, Li J, Lodrup Carlsen K, Louis R, MacNee W, Magard Y, Magnan A, Mahboub B, Mair A, Majer I, Makela MJ, Manning P, Mara S, Marshall GD, Masjedi MR, Matignon P, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Menzies-Gow A, Merk H, Michel JP, Miculinic N, Mihaltan F, Milenkovic B, Mohammad GM, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Morgan M, Mösges R, Mullol J, Nafti S, Namazova-Baranova L, Naclerio R, Neou A, Neffen H, Nekam K, Niggemann B, Ninot G, Nyembue TD, O'Hehir RE, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro P, Pali-Schöll I, Panzner P, Papadopoulos N, Papi A, Park HS, Passalacqua G, Pavord I, Pawankar R, Pengelly R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Poethig D, Pohl W, Popov TA, Portejoie F, Potter P, Postma D, Price D, Rabe KF, Raciborski F, Radier Pontal F, Repka-Ramirez S, Reitamo S, Rennard S, Rodenas F, Roberts J, Roca J, Rodriguez Mañas L, Rolland C, Roman Rodriguez M, Romano A, Rosado-Pinto J, Rosario N, Rosenwasser L, Rottem M, Ryan D, Sanchez-Borges M, Scadding GK, Schunemann HJ, Serrano E, Schmid-Grendelmeier P, Schulz H, Sheikh A, Shields M, Siafakas N, Sibille Y, Similowski T, Simons FE, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Sterk PJ, Sunyer J, Thijs C, To T, Todo-Bom A, Triggiani M, Valenta R, Valero AL, Valia E, Valovirta E, Van Ganse E, van Hage M, Vandenplas O, Vasankari T, Vellas B, Vestbo J, Vezzani G, Vichyanond P, Viegi G, Vogelmeier C, Vontetsianos T, Wagenmann M, Wallaert B, Walker S, Wang DY, Wahn U, Wickman M, Williams DM, Williams S, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zaidi A, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M, Mercier J: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clin Transl Allergy 2016; 6: 29.
442 Simoleit A, Wachter R, Gauger U, Werchan M, Werchan B, Zuberbier T, Bergmann KC: Pollen season of European beech (Fagus sylvatica L.) and temperature trends at two German monitoring sites over a more than 30-year period. Aerobiologia 2016; 32: 489–497.
441 Hawro T, Lehmann S, Altrichter S, Fluhr JW, Zubrebier T, Church MK, Maurer M, Metz : Skin provocation tests may help to diagnose atopic dermatitis. Allergy 2016; DOI: 10.1111/all.12995.
440 Zuberbier T, Abelson M, Akds CA, Bachert C; Berger U, Bindslev-Jensen C, Bousquet J, Canonica GW, Casale TB, Jutel M, Kowalski ML, Madonini E, Papadopoulos NG, Pfaar O, Sehlinger T, Bergmann KC: Validation of the GA²LEN chamber for trials in allergy. Innovation of a mobile allergen exposure chamber. J Allergy Clin Immunol 2016; doi: 10.1016/j.jaci.2016.08.025 [Epub ahead of print].
439 Hofmann MA, Kiecker F, Zuberbier T: A systematic review of the role of interleukin-17 and the interleukin-20 family in inflammatory allergic skin diseases. J Allergy Clin Immunol 2016; 16(5): 451-7.
438 Weller K, Peveling-Oberhag A, Altrichter S, Schoepke N, Abajian M, Zuberbier T, Staubach P, Maurer M: Instruments for the determination of disease activity, disease control, and impairment of quality of life in patients with chronic urticaria and angioedema. Allergologie 201: 39 (1): 6-15.
437 Siebenhaar F, Melde A, Magerl M, Zuberbier T, Maurer M: Histamine intolerance in patients with chronic spontaneous urtcaria. Eur Acad Dermatol Venereol 2016; 30(10): 1774-1777.
436 Staubach P, Zuberbier T, Vestergaard C, Siebenhaar F, Toubi E, Sussmann G: Controversies and challenges in the management of chronic urticaria. J Eur Acad Dermatol Venereol. 2016; 30 Suppl 5: 16-24.
435 Siebenhaar F, Melde A, Magerl M, Zuberbier T, Maurer M: Histamine intolerance in patients with chronic spontaneous urtcaria. Eur Acad Dermatol Venereol 2016; 30(10): 1774-1777.
434 Staubach P, Zuberbier T, Vestergaard C, Siebenhaar F, Toubi E, Sussmann G: Controversies and challenges in the management of chronic urticaria. J Eur Acad Dermatol Venereol. 2016; 30 Suppl 5: 16-24.
433 Maurer M, Giménez Arnau, Zuberbier T: What is new and upcoming in the world of chronic urticaria? J Eur Acad Dermatol Venereol. 2016 ;30 Suppl 5: 5-6.
432 Bousquet J, Schünemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A, Bergmann KC, Bosnic-Anticevich S, Brozek J, Calderon M, Canonica GW, Casale TB, Chavannes NH, Cox L, Chrystyn H, Cruz AA, Dahl R, De Carlo G, Demoly P, Devillier P, Dray G, Fletcher M, Fokkens WJ, Fonseca J, Gonzalez-Diaz SN, Grouse L, Keil T, Kuna P, Larenas-Linnemann D, Lodrup Carlsen KC, Meltzer EO, Mullol J, Muraro A, Naclerio RN, Palkonen S, Papadopoulos NG, Passalacqua G, Price D, Ryan D, Samolinski B, Scadding GK, Sheikh A, Valiulis A, Valovirta E, Walker S, Wickman M, Yorgancioglu A, Zuberbier T: MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol 2016; 138(2): 367-374.
431 Graham J, McBride D, Stull D, Halliday A, Alexopoulos ST, Balp MM, Griffiths M, Agirrezabal I, Zuberbier T, Brennan A: Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria. Pharmacoeconomics 2016; 34(8): 815-27.
430 Makowska JS, Burney P, Jarvis D, Keil T, Tomassen P, Bislimovska J, Brozek G, Bachert C, Baelum J, Bindslev-Jensen C, Bousquet J, Bousquet P, Kai-Håkon C, Dahlen SE, Dahlen B, Fokkens WJ, Forsberg B, Gjomarkaj M, Howarth P, Salagean E, Janson C, Kasper L, Kraemer U, Louiro C, Lundback B, Minov J, Nizankowska-Mogilnicka E, Papadopoulos N, Sakellariou AG, Todo-Bom A, Toskala E, Zejda JE, Zuberbier T, Kowalski ML: Respiratory hypersensitivity reactions to NSAIDs in Europe: the global allergy and asthma network (GA2LEN) survey. Allergy 2016; 71(11): 1603-1611.
429 Sawatzky S, Schario M, Stroux A, Lünnemann L, Zuberbier T, Blume-Peytavi U, Garcia Bartels N: Children with Dry Skin and Atopic Predisposition: Outcome Measurement with Validated Scores for Atopic Dermatitis. Skin Pharmacol Physiol 2016; 29: 148-156.
428 Frombach J, Sonnenburg A, Krapohl BD, Zuberbier T, Stahlmann R, Schreiner M: Erratum to: A novel method to generate monocyte-derived dendritic cells during coculture with HaCaT facilitates detection of weak contact allergens in cosmetics. Arch Toxicol 2016; 91(1): 351.
427 Metz M, Bindslev-Jensen C, Bousquet J, Canonica GW, Church MK, Godse KV, Grattan CEJ, Hide M, Kocatürk E, Magerl M, Makris M, Meshkova R, Saini, SS, Sussman G., Toubi E., Zhao Z., Zuberbier T.: Definition, aims, and implementation of GA²LEN Urticaria Centers of Reference and Excellence. Allergy 2016; 71(8): 1210-8.
426 Magerl M, Altrichter S, Borzova E, Giménez‐Arnau A, Grattan CEH, Lawlor F, Mathelier‐Fusade P, Meshkova RY, Zuberbier T, Metz M, Maurer M: The definition, diagnostic testing, and management of chronic inducible urticarias–The EAACI/GA2LEN/EDF/UNEV consensus recommendations 2016 update and revision. Allergy 2016; 71 (6): 780-802.
425 Zuberbier T, Hengstenberg C: Risk hidden in the small print? Some food additives may trigger pseudoallergic reactions. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2016; 59(6): 777-82.
424 Frombach J, Sonnenburg A, Krapohl BD, Zuberbier T, Stahlmann R, Schreiner M.: Erratum to: A novel method to generate monocyte-derived dendritic cells during coculture with HaCaT facilitates detection of weak contact allergens in cosmetics. Arch Toxicol. 2017; 91(1): 351.
423 Bousquet J, Caimmi DP, Bedbrook A, Bewick M, Hellings PW, Devillier P, Arnavielhe S, Bachert C, Bergmann KC, Canonica GW, Chavannes N, Cruz AA, Dahl R, Demoly P, De Vries G, Mathieu-Dupas E, Fink Wagner A, Fonseca J, Guldemond N, Haahtela T, Hellqvist-Dahl B, Just J, Keil T, Klimek L, Kowalski ML, Kuitunen M, Kuna P, Kvedariene V, Laune D, Pereira AM, Carreiro-Martins P, Melén E, Morais-Almeida M, Mullol J, Muraro A, Murray R, Nogueira-Silva L, Papadopoulos NG, Passalacqua G, Portejoie F, Price D, Ryan D, Samolinski B, Sheikh A, Siroux V, Spranger O, Bom AT, Tomazic PV, Valero A, Valovirta E, Valiulis A, VandenPlas O, van der Meulen S, van Eerd M, Wickman M, Zuberbier T: Pilot study of mobile phone technology in allergic rhinitis in European countries. The MASK-rhinitis study. Allergy 2017. doi: 10.1111/all.13125 [Epub ahead of print].
422 Bousquet J, Bewick M, Cano A, Eklund P, Fico G, Goswami N, Guldemond NA, Henderson D, Hinkema MJ, Liotta G, Mair A, Molloy W, Monaco A, Monsonis-Paya I, Nizinska A, Papadopoulos H, Pavlickova A, Pecorelli S, Prados-Torres A, Roller-Wirnsberger RE, Somekh D, Vera-Muñoz C, Visser F, Farrell J, Malva J, Andersen Ranberg K, Camuzat T, Carriazo AM, Crooks G, Gutter Z, Iaccarino G, Manuel de Keenoy E, Moda G, Rodriguez-Mañas L, Vontetsianos T, Abreu C, Alonso J, Alonso-Bouzon C, Ankri J, Arredondo MT, Avolio F, Bedbrook A, Białoszewski AZ, Blain H, Bourret R, Cabrera-Umpierrez MF, Catala A, O'Caoimh R, Cesari M, Chavannes NH, Correia-da-Sousa J, Dedeu T, Ferrando M, Ferri M, Fokkens WJ, Garcia-Lizana F, Guérin O, Hellings PW, Haahtela T, Illario M, Inzerilli MC, Lodrup Carlsen KC, Kardas P, Keil T, Maggio M, Mendez-Zorrilla A, Menditto E, Mercier J, Michel JP, Murray R, Nogues M, O'Byrne-Maguire I, Pappa D, Parent AS, Pastorino M, Robalo-Cordeiro C, Samolinski B, Siciliano P, Teixeira AM, Tsartara SI, Valiulis A, Vandenplas O, Vasankari T, Vellas B, Vollenbroek-Hutten M, Wickman M, Yorgancioglu A, Zuberbier T, Barbagallo M, Canonica GW, Klimek L, Maggi S, Aberer W, Akdis C, Adcock IM, Agache I, Albera C, Alonso-Trujillo F, Angel Guarcia M, Annesi-Maesano I, Apostolo J, Arshad SH, Attalin V, Avignon A, Bachert C, Baroni I, Bel E, Benson M, Bescos C, Blasi F, Barbara C, Bergmann KC, Bernard PL, Bonini S, Bousquet PJ, Branchini B, Brightling CE, Bruguière V, Bunu C, Bush A, Caimmi DP, Calderon MA, Canovas G, Cardona V, Carlsen KH, Cesario A, Chkhartishvili E, Chiron R, Chivato T, Chung KF, d'Angelantonio M, De Carlo G, Cholley D, Chorin F, Combe B, Compas B, Costa DJ, Costa E, Coste O, Coupet AL, Crepaldi G, Custovic A, Dahl R, Dahlen SE, Demoly P, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Du Toit G, Dubakiene R, Dupeyron A, Emuzyte R, Fiocchi A, Wagner A, Fletcher M, Fonseca J, Fougère B, Gamkrelidze A, Garces G, Garcia-Aymeric J, Garcia-Zapirain B, Gemicioğlu B, Gouder C, Hellquist-Dahl B, Hermosilla-Gimeno I, Héve D, Holland C, Humbert M, Hyland M, Johnston SL, Just J, Jutel M, Kaidashev IP, Khaitov M, Kalayci O, Kalyoncu AF, Keijser W, Kerstjens H, Knezović J, Kowalski M, Koppelman GH, Kotska T, Kovac M, Kull I, Kuna P, Kvedariene V, Lepore V, MacNee W, Maggio M, Magnan A, Majer I, Manning P, Marcucci M, Marti T, Masoli M, Melen E, Miculinic N, Mihaltan F, Milenkovic B, Millot-Keurinck J, Mlinarić H, Momas I, Montefort S, Morais-Almeida M, Moreno-Casbas T, Mösges R, Mullol J, Nadif R, Nalin M, Navarro-Pardo E, Nekam K, Ninot G, Paccard D, Pais S, Palummeri E, Panzner P, Papadopoulos NK, Papanikolaou C, Passalacqua G, Pastor E, Perrot M, Plavec D, Popov TA, Postma DS, Price D, Raffort N, Reuzeau JC, Robine JM, Rodenas F, Robusto F, Roche N, Romano A, Romano V, Rosado-Pinto J, Roubille F, Ruiz F, Ryan D, Salcedo T, Schmid-Grendelmeier P, Schulz H, Schunemann HJ, Serrano E, Sheikh A, Shields M, Siafakas N, Scichilone N, Siciliano P, Skrindo I, Smit HA, Sourdet S, Sousa-Costa E, Spranger O, Sooronbaev T, Sruk V, Sterk PJ, Todo-Bom A, Touchon J, Tramontano D, Triggiani M, Tsartara SI, Valero AL, Valovirta E, van Ganse E, van Hage M, van den Berge M, Vandenplas O, Ventura MT, Vergara I, Vezzani G, Vidal D, Viegi G, Wagemann M, Whalley B, Wickman M, Wilson N, Yiallouros PK, Žagar M, Zaidi A, Zidarn M, Hoogerwerf EJ, Usero J, Zuffada R, Senn A, de Oliveira-Alves B.: Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA. J Nutr Health Aging 2017;21(1): 92-104.
421 Braido F, Scichilone N, Lavorini F, Usmani OS, Dubuske L, Boulet LP, Mosges R, Nunes C, Sanchez-Borges M, Ansotegui IJ, Ebisawa M, Levi-Schaffer F, Rosenwasser LJ, Bousquet J, Zuberbier T, Canonica GW, Cruz A, Yanez A, Yorgancioglu A, Deleanu D, Rodrigo G, Berstein J, Ohta K, Vichyanond P, Pawankar R, Gonzalez-Diaz SN, Nakajima S, Slavyanskaya T, Fink-Wagner A, Loyola CB, Ryan D, Passalacqua G, Celedon J, Ivancevich JC, Dobashi K, Zernotti M, Akdis M, Benjaponpitak S, Bonini S, Burks W, Caraballo L, El-Sayed ZA, Fineman S, Greenberger P, Hossny E, Ortega-Martell JA, Saito H, Tang M, Zhang L; for Interasma Executive Board.; ARIA; GA²LEN: Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA²LEN). World Allergy Organ J 2016; 9(1): 37.
420 Kowalski ML, Ansotegui I, Aberer W, Al-Ahmad M, Akdis M, Ballmer-Weber BK, Beyer K, Blanca M, Brown S, Bunnag C, Hulett AC, Castells M, Chng HH, De Blay F, Ebisawa M, Fineman S, Golden DB, Haahtela T, Kaliner M, Katelaris C, Lee BW, Makowska J, Muller U, Mullol J, Oppenheimer J, Park HS, Parkerson J, Passalacqua G, Pawankar R, Renz H, Rueff F, Sanchez-Borges M, Sastre J, Scadding G, Sicherer S, Tantilipikorn P, Tracy J, van Kempen V, Bohle B, Canonica GW, Caraballo L, Gomez M, Ito K, Jensen-Jarolim E, Larche M, Melioli G, Poulsen LK, Valenta R, Zuberbier T: Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement. World Allergy Organ J. 2016; 9(1): 33.
419 Barmeyer C, Schumann M, Meyer T, Zielinski C, Zuberbier T, Siegmund B, Schulzke JD, Daum S, Ullrich R: Long-term response to gluten-free diet as evidence for non-celiac wheat sensitivity in one third of patients with diarrhea-dominant and mixed-type irritable bowel syndrome. Int J Colorectal Dis 2016: DOI 10.1007/s00384-016-2663-x.
418 Babina M, Guhl S, Artuc M, Zuberbier T: Skin mast cell phenotypes between two highly divergent cohorts - more pronounced variability within than between groups. Exp Dermatol 2016. doi: 10.1111/exd.13227.
417 Babina M, Guhl S, Artuc M, Zuberbier T: IL-4 and human skin mast cells revisited: reinforcement of a pro-allergic phenotype upon prolonged exposure. Arch Dermatol Res 2016; 308(9): 665-670.
416 Bousquet J, Farrell J, Crooks G, Hellings P, Bel EH, Bewick M, Chavannes NH, de Sousa JC, Cruz AA, Haahtela T, Joos G, Khaltaev N, Malva J, Muraro A, Nogues M, Palkonen S, Pedersen S, Robalo-Cordeiro C, Samolinski B, Strandberg T, Valiulis A, Yorgancioglu A, Zuberbier T, Bedbrook A, Aberer W, Adachi M, Agusti A, Akdis CA, Akdis M, Ankri J, Alonso A, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arnavielhe S, Arshad H, Bai C, Baiardini I, Bachert C, Baigenzhin AK, Barbara C, Bateman ED, Beghé B, Kheder AB, Bennoor KS, Benson M, Bergmann KC, Bieber T, Bindslev-Jensen C, Bjermer L, Blain H, Blasi F, Boner AL, Bonini M, Bonini S, Bosnic-Anticevitch S, Boulet LP, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Burney PG, Bush A, Caballero-Fonseca F, Caimmi D, Calderon MA, Calverley PM, Camargos PA, Canonica GW, Camuzat T, Carlsen KH, Carr W, Carriazo A, Casale T, Cepeda Sarabia AM, Chatzi L, Chen YZ, Chiron R, Chkhartishvili E, Chuchalin AG, Chung KF, Ciprandi G, Cirule I, Cox L, Costa DJ, Custovic A, Dahl R, Dahlen SE, Darsow U, De Carlo G, De Blay F, Dedeu T, Deleanu D, De Manuel Keenoy E, Demoly P, Denburg JA, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, Emuzyte R, Fabbri LM, Fletcher M, Fiocchi A, Fink Wagner A, Fonseca J, Fokkens WJ, Forastiere F, Frith P, Gaga M, Gamkrelidze A, Garces J, Garcia-Aymerich J, Gemicioğlu B, Gereda JE, González Diaz S, Gotua M, Grisle I, Grouse L, Gutter Z, Guzmán MA, Heaney LG, Hellquist-Dahl B, Henderson D, Hendry A, Heinrich J, Heve D, Horak F, Hourihane JO, Howarth P, Humbert M, Hyland ME, Illario M, Ivancevich JC, Jardim JR, Jares EJ, Jeandel C, Jenkins C, Johnston SL, Jonquet O, Julge K, Jung KS, Just J, Kaidashev I, Kaitov MR, Kalayci O, Kalyoncu AF, Keil T, Keith PK, Klimek L, Koffi N'Goran B, Kolek V, Koppelman GH, Kowalski ML, Kull I, Kuna P, Kvedariene V, Lambrecht B, Lau S, Larenas-Linnemann D, Laune D, Le LT, Lieberman P, Lipworth B, Li J, Lodrup Carlsen K, Louis R, MacNee W, Magard Y, Magnan A, Mahboub B, Mair A, Majer I, Makela MJ, Manning P, Mara S, Marshall GD, Masjedi MR, Matignon P, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Menzies-Gow A, Merk H, Michel JP, Miculinic N, Mihaltan F, Milenkovic B, Mohammad GM, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Morgan M, Mösges R, Mullol J, Nafti S, Namazova-Baranova L, Naclerio R, Neou A, Neffen H, Nekam K, Niggemann B, Ninot G, Nyembue TD, O'Hehir RE, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro P, Pali-Schöll I, Panzner P, Papadopoulos N, Papi A, Park HS, Passalacqua G, Pavord I, Pawankar R, Pengelly R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Poethig D, Pohl W, Popov TA, Portejoie F, Potter P, Postma D, Price D, Rabe KF, Raciborski F, Radier Pontal F, Repka-Ramirez S, Reitamo S, Rennard S, Rodenas F, Roberts J, Roca J, Rodriguez Mañas L, Rolland C, Roman Rodriguez M, Romano A, Rosado-Pinto J, Rosario N, Rosenwasser L, Rottem M, Ryan D, Sanchez-Borges M, Scadding GK, Schunemann HJ, Serrano E, Schmid-Grendelmeier P, Schulz H, Sheikh A, Shields M, Siafakas N, Sibille Y, Similowski T, Simons FE, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Sterk PJ, Sunyer J, Thijs C, To T, Todo-Bom A, Triggiani M, Valenta R, Valero AL, Valia E, Valovirta E, Van Ganse E, van Hage M, Vandenplas O, Vasankari T, Vellas B, Vestbo J, Vezzani G, Vichyanond P, Viegi G, Vogelmeier C, Vontetsianos T, Wagenmann M, Wallaert B, Walker S, Wang DY, Wahn U, Wickman M, Williams DM, Williams S, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zaidi A, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M, Mercier J. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clin Transl Allergy 2016; 6: 29.
415 Hawro T, Lehmann S, Altrichter S, Fluhr JW, Zuberbier T, Church MK, Maurer M, Metz M: Skin provocation tests may help to diagnose atopic dermatitis. Allergy 2016; 71(12): 1745-1752.
414 Zuberbier T, Abelson M, Akds CA, Bachert C; Berger U, Bindslev-Jensen C, Bousquet J, Canonica GW, Casale TB, Jutel M, Kowalski ML, Madonini E, Papadopoulos NG, Pfaar O, Sehlinger T, Bergmann KC: Validation of the GA²LEN chamber for trials in allergy. Innovation of a mobile allergen exposure chamber. J Allergy Clin Immunol 2016 doi: 10.1016/j.jaci.2016.08.025.
413 Hofmann MA, Kiecker F, Zuberbier T: A systematic review of the role of interleukin-17 and the interleukin-20 family in inflammatory allergic skin diseases. Curr Opin Allergy Clin Immunol 2016; in print: ACI160508.
412 Siebenhaar F, Melde A, Magerl M, Zuberbier T, Maurer M: Histamine intolerance in patients with chronic spontaneous urtcaria. J Eur Acad Dermatol Venereol. 2016; 30(10): 1774-1777.
411 Staubach P, Zuberbier T, Vestergaard C, Siebenhaar F, Toubi E, Sussmann G: Controversies and challenges in the management of chronic urticaria. J Eur Acad Dermatol Venereol 2016; 30 Suppl 5: 16-24.
410 Maurer M, Giménez Arnau, Zuberbier T: What is new and upcoming in the world of chronic urticaria? J Eur Acad Dermatol Venereol 2016; 30 Suppl 5: 5-6.
409 Bousquet J, Schünemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A, Bergmann KC, Bosnic-Anticevich S, Brozek J, Calderon M, Canonica GW, Casale TB, Chavannes NH, Cox L, Chrystyn H, Cruz AA, Dahl R, De Carlo G, Demoly P, Devillier P, Dray G, Fletcher M, Fokkens WJ, Fonseca J, Gonzalez-Diaz SN, Grouse L, Keil T, Kuna P, Larenas-Linnemann D, Lodrup Carlsen KC, Meltzer EO, Mullol J, Muraro A, Naclerio RN, Palkonen S, Papadopoulos NG, Passalacqua G, Price D, Ryan D, Samolinski B, Scadding GK, Sheikh A, Valiulis A, Valovirta E, Walker S, Wickman M, Yorgancioglu A, Zuberbier T, MASK study group: MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol 2016; 138(2): 367-374.
408 Makowska JS, Burney P, Jarvis D, Keil T, Tomassen P, Bislimovska J, Brozek G, Bachert C, Baelum J, Bindslev-Jensen C, Bousquet J, Bousquet PJ, Kai-Håkon C, Dahlen SE, Dahlen B, Fokkens WJ, Forsberg B, Gjomarkaj M, Howarth P, Janson C, Kasper L, Kraemer U, Louiro C, Lundback B, Minov J, Nizankowska-Mogilnicka E, Papadopoulos N, Sakellariou AG, Todo-Bom A, Toskala E, Zejda JE, Zuberbier T, Kowalski ML: Respiratory Hypersensitivity Reactions to NSAIDs in Europe: The Global Allergy and Asthma Network (GA2 LEN) Survey. Allergy 2016; DOI: 10.1111/all.12941.
407 Graham J, McBride D, Stull D, Halliday A, Alexopoulos ST, Balp MM, Griffiths M, Agirrezabal I, Zuberbier T, Brennan A: Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria. Pharmacoeconomics 2016; 34(8): 815-27.
406 Weller K, Peveling-Oberhag A, Altrichter S, Schoepke N, Abajian M, Zuberbier T, Staubach P, Maurer M: Instruments for the determination of disease activity, disease control, and impairment of quality of life in patients with chronic urticaria and angioedema. Allergologie 2016; 39(1): 6-15.
405 Maurer M, Metz M, Bindslev-Jensen C, Bousquet J, Canonica GW, Church MK, Godse KV, Grattan CEJ, Hide M, Kocatürk E, Magerl M, Makris M, Meshkova R, Saini, SS, Sussman G., Toubi E., Zhao Z., Zuberbier T., Gimenez-Arnau A: Definition, aims, and implementation of GA²LEN Urticaria Centers of Reference and Excellence. Allergy 2016; DOI: 10.1111/all.12901.
404 Magerl M, Altrichter S, Borzova E, Giménez‐Arnau A, Grattan CEH, Lawlor F, Mathelier‐Fusade P, Meshkova RY, Zuberbier T, Metz M, Maurer M: The definition, diagnostic testing, and management of chronic inducible urticaria – The EAACI/GA2LEN/EDF/UNEV consensus recommendations 2016 update and revision. Allergy 2016; 71(6): 780-802.
403 Zuberbier T, Hengstenberg C: Risk hidden in the small print? Some food additives may trigger pseudoallergic reactions. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2016; 59(6): 777-782.
402 Frombach J, Sonnenburg A, Krapohl BD, Zuberbier T, Stahlmann R, Schreiner M: A novel method to generate monocyte-derived dendritic cells during coculture with HaCaT facilitates detection of weak contact allergens in cosmetics. Arch Toxicol 2016; DOI:10.1007/s00204-016-1722-y.
137 Bousquet J, Barbara C, Bateman E, Bel E, Bewick M, Chavannes NH, Cruz AA, Haahtela T, Hellings PW, Khaltaev N, Lodrup Carlsen K, Muraro A, Cordeiro CR, Rosado-Pinto J, Samolinski B, Strandberg T, Valiulis A, Yorgancioglu A, Zuberbier T: AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation. Eur Respir J 2016; 47(4): 1028-33.
401 Bousquet J, Anto JM, Akdis M, Auffray C, Keil T, Momas I, Postma D, Valenta R, Wickman M, Cambon-Thomsen A, Haahtela T, Lambrecht BN, Lodrup-Carlsen K, Koppelman GH, Sunyer J, Zuberbier T, Annesi-Maesano I, Arno A, Bindslev-Jensen C, De Carlo G, Forastiere F, Heinrich J, Kowalski ML, Maier D, Melén E, Palkonen S, Smit HA, Standl M, Wright J, Arsanoj A, Benet M, Balardini N, Garcia-Aymerich J, Gehring U, Guerra S, Hohman C, Kull I, Lupinek C, Pinart M, Skrindo I, Westman M, Smagghe D, Akdis C, Albang R, Anastasova V, Anderson N, Bachert C, Ballereau S, Ballester F, Basagana X, Bedbrook A, Bergstrom A, von Berg A, Brunekreef B, Burte E, Carlsen KH, Chatzi L, Coquet JM, Curin M, Demoly P, Eller E, Fantini MP, Gerhard B, Hammad H, von Hertzen L, Hovland V, Jacquemin B, Just J, Keller T, Kerkhof M, Kiss R, Kogevinas M, Koletzko S, Lau S, Lehmann I, Lemonnier N, McEachan R, Mäkelä M, Mestres J, Minina E, Mowinckel P, Nadif R, Nawijn M, Oddie S, Pellet J, Pin I, Porta D, Rancière F, Rial-Sebbag A, Saes Y, Schuijs MJ, Siroux V, Tischer CG, Torrent M, Varraso R, De Vocht J, Wenger K, Wieser S, Xu C: Paving the way of systems biology and precision medicine in allergic diseases: The MeDALL success story. Allergy 2016; DOI: 10.1111/all.12880.
400 Maurer M, Vena GA, Cassano N, Zuberbier T: Current and future therapies for treating chronic spontenous urticaria. Expert Opin Pharmacother 2016; 17(8): 1131-1139.
399 Worm M, Reese I, Ballmer-Weber B, Beyer K, Bischoff SC, Classen M, Fischer PJ, Fuchs T, Huttegger I, Jappe U, Klimek L, Koletzko B, Lange L, Lepp U, Mahler V, Niggemann B, Rabe U, Raithel M, Saloga J, Schäfer C, Schnadt S, Schreiber J, Szépfalusi Z, Treudler R, Wagenmann M, Watzl B, Werfel T, Zuberbier T, Kleine-Tebbe J: Guidelines on the management of IgE-mediated food allergies: S2k-Guidelines of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Medical Association of Allergologists (AeDA), the German Professional Association of Pediatricians (BVKJ), the German Allergy and Asthma Association (DAAB), German Dermatological Society (DDG), the German Society for Nutrition (DGE), the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS), the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery, the German Society for Pediatric and Adolescent Medicine (DGKJ), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Society for Pneumology (DGP), the German Society for Pediatric Gastroenterology and Nutrition (GPGE), German Contact Allergy Group (DKG), the Austrian Society for Allergology and Immunology (Æ-GAI), German Professional Association of Nutritional Sciences (VDOE) and the Association of the Scientific Medical Societies Germany (AWMF). Allergo J Int 2015; 24: 256-293.
398 Simoleit A, Wachter R, Gauger U, Werchan B, Zuberbier T, Bergmann KC: Pollen season of European beech (Fagus sylvatica L.) and temperature trends at two German monitoring sites over a more than 30-year period. Aerobiologia 2016; DOI 10.1007/s10453-016-9421-y.
397 Babina M, Guhl S, Artuc M, Trivedi N, Zuberbier T: Phenotypic variability in human skin mast cells. Exp Dermatol 2016; 25(6): 434-439.
396 Worm M, Jappe U, Kleine-Tebbe J, Schäfer C, Reese I, Saloga J, Treudler R, Zuberbier T, Wassmann A, Fuchs T, Dölle S, Raithel M, Ballmer-Weber B, Niggemann B: Food allergies resulting from immunological cross-reactivity with inhalant allergens. Allergo J Int 2014; 23(1): 1-16.
395 Muraro A, Fokkens WJ, Pietikainen S, Borrelli D, Agache I, Bousquet J, Costigliola V, Joos G, Lund VJ, Poulsen LK, Price D, Rolland Z, Zuberbier T, Hellings PW: European Symposium on Precision Medicine in Allergy and Airways Diseases: Report of the European Union Parliament Symposium (Oct. 14, 2015). Allergy 2016; 71(5): 583-7.
394 Vietri J, Tian H, Gabriel S, Balp M, Khalil S, Zuberbier T: Economic Burden of Chronic Spontaneous Urticaria And Psoriasis: Patients Perspective From Europe. Value Health 2015; 18(7): A424-425.
393 Balp M, Khalil S, Tian H, Gabriel S, Vietri J, Zuberbier T: Humanistic Burden of Chronic Spontaneous Urticaria in Comparison to Psoriasis: European Perspective. Value Health 2015; 18(7): A706.
392 Babina M, Guhl S, Motakis E, Artuc M, Hazzan T, Worm M, Forrest AR, Zuberbier T: Retinoic acid potentiates inflammatory cytokines in human mast cells: Identification of mast cells as prominent constituents of the skin retinoid network. Mol Cell Endocrinol 2015; 406: 49-59.
391 Reese I, Holzhauser T, Schnadt S, Dölle S, Kleine-Tebbe J, Raithel M, Worm M, Zuberbier T, Vieths S: Allergen and allergy risk assessment, allergen management, and gaps in the European Food Information Regulation (FIR)*.Allergo J Int. 2015; 24: 180–184.
390 Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, Casale T, Cruz AA, Demoly P, Hellings P, Valiulis A, Wickman M, Zuberbier T, Bosnic-Anticevitch S, Bedbrook A, Bergmann KC, Caimmi D, Dahl R, Fokkens WJ, Grisle I, Lodrup Carlsen K, Mullol J, Muraro A, Palkonen S, Papadopoulos N, Passalacqua G, Ryan D, Valovirta E, Yorgancioglu A, Aberer W, Agache I, Adachi M, Akdis CA, Akdis M, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arnavielle S, Arshad H, Baiardini I, Baigenzhin AK, Barbara C, Bateman ED, Beghé B, Bel EH, Ben Kheder A, Bennoor KS, Benson M, Bewick M, Bieber T, Bindslev-Jensen C, Bjermer L, Blain H, Boner AL, Boulet LP, Bonini M, Bonini S, Bosse I, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Burney PG, Bush A, Caballero-Fonseca F, Calderon MA, Camargos P, Camuzat T, Carlsen KH, Carr W, Cepeda Sarabia AM, Chavannes NH, Chatzi L, Chen YZ, Chiron R, Chkhartishvili E, Chuchalin AG, Ciprandi G, Cirule I, Correia de Sousa J, Cox L, Crooks G, Costa DJ, Custovic A, Dahlen SE, Darsow U, De Carlo G, De Blay F, Dedeu T, Deleanu D, Denburg JA, Devillier P, Didier A, Dinh-Xuan AT, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, Emuzyte R, Fink Wagner A, Fletcher M, Fiocchi A, Forastiere F, Gamkrelidze A, Gemicioğlu B, Gereda JE, González Diaz S, Gotua M, Grouse L, Guzmán MA, Haahtela T, Hellquist-Dahl B, Heinrich J, Horak F, Hourihane J, Howarth P, Humbert M, Hyland ME, Ivancevich JC, Jares EJ, Johnston SL, Joos G, Jonquet O, Jung KS, Just J, Kaidashev I, Kalayci O, Kalyoncu AF, Keil T, Keith PK, Khaltaev N, Klimek L, N'Goran BK, Kolek V, Koppelman GH, Kowalski ML, Kull I, Kuna P, Kvedariene V, Lambrecht B, Lau S, Larenas-Linnemann D, Laune D, Le L, Lieberman P, Lipworth B, Li J, Louis R, Magard Y, Magnan A, Mahboub B, Majer I, Makela MJ, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Mohammad Y, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Mösges R, Namazova-Baranova L, Naclerio R, Neou A, Neffen H, Nekam K, Niggemann B, Nyembue TD, O'Hehir RE, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro P, Pali-Schöll I, Palmer S, Panzner P, Papi A, Park HS, Pavord I, Pawankar R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov TA, Portejoie F, Postma D, Potter P, Price D, Rabe KF, Raciborski F, Radier Pontal F, Repka-Ramirez S, Robalo-Cordeiro C, Rolland C, Rosado-Pinto J, Reitamo S, Rodenas F, Roman Rodriguez M, Romano A, Rosario N, Rosenwasser L, Rottem M, Sanchez-Borges M, Scadding GK, Serrano E, Schmid-Grendelmeier P, Sheikh A, Simons F, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Strandberg T, Sunyer J, Thijs C, Todo-Bom A, Triggiani M, Valenta R, Valero AL, van Hage M, Vandenplas O, Vezzani G, Vichyanond P, Viegi G, Wagenmann M, Walker S, Wang DY, Wahn U, Williams DM, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M, Mercier J: MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy 2015; 70(11): 1372-92.
389 Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, Fuchs T, Jakob T, Lange L, Pfützner W, Mockenhaupt M, Ott H, Pfaar O, Ring J, Sachs B, Sitter H, Trautmann A, Treudler R, Wedi B, Worm M, Wurpts G, Zuberbier T, Merk HF: Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (ÖGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM). Allergo J Int 2015; 24(3): 94-105.
388 Maurer M, Gimenez-Arnau. What is urticaria? Expert opinion from the 1st Global Urticaria Forum. J Eur Acad Dermatol Venereol 2015; 29 Suppl 3: 1-2.
387 Simoleit A, Gauger U, Mücke HG, Werchan M, Obstova B, Zuberbier T, Bergmann KC: Intradiurnal patterns of allergenic airborne pollen near a city motorway in Berlin, Germany. Aerobiologia 2016; 32(2): 199–209.
386 Weller K, Zuberbier T, Maurer M: Chronic urticaria: tools to aid the diagnosis and assessment of disease status in daily practice. J Eur Acad Dermatol Venereol 2015; 29 Suppl 3: 38-44.
385 Toubi E, Grattan C, Zuberbier T: Diagnostic dilemmas in chronic urticaria. J Eur Acad Dermatol Venereol 2015, 29 Suppl. 3, 12-15.
384 Gimenez-Arnau AM, Grattan C, Zuberbier T, Toubi E: An individualized diagnostic approach based on guidelines for chronic urticaria. J Eur Acad Dermatol Venereol 2015; 29 Suppl 3: 3-11.
383 Frohwein TA, Sonnenburg A, Zuberbier T, Stahlmann R, Schreiner M: Unsaturated compounds induce up-regulation of CD86 on dendritic cells in the in vitro sensitization assay LCSA. Arch Toxicol 2016; 90(4): 927-36.
382 Czaika VA, Zuberbier T: Lokale Kombinationstherapie bei entzündlichen Dermatomykosen. Hautarzt. 2015; 66: 360-369.
381 Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, Church MK, Ensina LF, Giménez-Arnau A, Godse K, Gonçalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Abdul Latiff AH, Mathelier-Fusade P, Metz M, Nast A, Saini SS, Sánchez-Borges M, Schmid-Grendelmeier P, Simons FE, Staubach P, Sussman G, Toubi E, Vena GA, Wedi B, Zhu XJ, Maurer M: Wytyczne EAACI/GA2LEN/EDF/WAO dotyczace definicji, klasyfikacji, rozpoznawania i leczenia pokrzywki: weryfikacja z 2013 roku z poprawkami. Przegl Dermatol 2015; 102: 155-179.
380 Bousquet J, Anto JM, Wickman M, Keil T, Valenta R, Haahtela T, Lodrup Carlsen K, van Hage M, Akdis C, Bachert C, Akdis M, Auffray C, Annesi-Maesano I, Bindslev-Jensen C, Cambon-Thomsen A, Carlsen KH, Chatzi L, Forastiere F, Garcia-Aymerich J, Gehrig U, Guerra S, Heinrich J, Koppelman GH, Kowalski ML, Lambrecht B, Lupinek C, Maier D, Melén E, Momas I, Palkonen S, Pinart M, Postma D, Siroux V, Smit HA, Sunyer J, Wright J, Zuberbier T, Arshad SH, Nadif R, Thijs C, Anderson N, Arsanoj A, Balardini N, Ballereau S, Bedbrook A, Benet M, Bergstrom A, Brunekreef B, Burte E, Calderon M, De Carlo G, Demoly P, Eller E, Fantini MP, Hammad H, Hohman C, Just J, Kerkhof M, Kogevinas M, Kull I, Lau S, Lemonnier N, Mommers M, Nawijn M, Neubauer A, Oddie S, Pellet J, Pin I, Porta D, Saes Y, Skrindo I, Tischer CG, Torrent M, von Hertzen L: Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal Type 2 signalling? The MeDALL hypothesis. Allergy 2015; 70(9): 1062-1078.
379 Weller K, Zuberbier T, Maurer M: Clinically relevant outcome measures for assessing disease activity, disease control and quality of life impairment in patients with chronic spontaneous urticaria and recurrent angioedema. Curr Opin Allergy Clin Immunol 2015; 15: 220–226.
378 Zuberbier T, Maurer M: Omalizumab for the treatment of chronic urticaria. Expert Rev Clin Immunol 2015, 11(2): 171-80.
377 Bergmann KC, Zuberbier T, Church MK: Omalizumab in the treatment of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract 2015; 3(3): 459-460.
376 Traidl-Hoffmann C, Treudler R, Pryzbilla B, Kapp A, Zuberbier T, Werfel T: Die Arbeitsgemeinschaft Allergologie in der DDG. J Dtsch Dermatol Ges 2014; 12: 46–48.
375 Guhl S, Neou A, Artuc M, Zuberbier T, Babina, M: Skin mast cells develop non-synchronized changes in typical lineage characteristics upon culture. Exp Dermatol 2014; 23: 922–941.
374 Kim J, Guhl S, Babina M, Zuberbier T, Artuc M: Integration of the Human Dermal Mast Cell into the Organotypic Co-culture Skin Model. Methods Mol Biol 2014; 1192: 69-85.
373 Brandt O, Zuberbier T, Bergmann KC: Risk of sensitization and allergy in Ragweed workers - a pilot study. Allergy Asthma Clin Immunol 2014; 10: 42.
372 Makris M, Papadavid E, Zuberbier T: The use of biologicals in cutaneous allergies - present and future. Curr Opin Allergy Clin Immunol 2014; 14: 409-416.
371 Zuberbier T, Lötvall J, Simoens S, Subramanian S, Church MK: Economic Burden of Inadequate Management of Allergic Diseases in the European Union: a GA²LEN Review. Allergy 2014; 69: 1275–1279.
370 Zuberbier T: State of the Art: Allergologie. Kompendium Dermatologie 2014; 10: 6-8.
369 Babina M, Motakis E, Zuberbier T: Mast cell transcriptome elucidation: what are the implications for allergic disease in the clinic and where do we go next? Expert Rev Clin Immunol 2014; 10: 977-980.
368 Jappe U, Kleine-Tebbe J, Schäfer C, Reese I, Saloga J, Treudler R, Zuberbier T, Wassmann A, Fuchs T, Dölle S, Raithel M, Ballmer-Weber B, Niggemann B, Werfel T: Nahrungsmittelallergie infolge immunologischer Kreuzreaktivitäten mit Inhalationsallergenen. Allergologie 2014; 37: 170-189.
367 Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, Annesi-Maesano I, Anto JM, Bachert C, Baena-Cagnani CE, Bai C, Baigenzhin A, Barbara C, Barnes PJ, Bateman ED, Beck L, Bedbrook A, Bel EH, Benezet O, Bennoor KS, Benson M, Bernabeu-Wittel M, Bewick M, Bindslev-Jensen C, Blain H, Blasi F, Bonini M, Bonini S, Boulet LP, Bourdin A, Bourret R, Bousquet PJ, Brightling CE, Briggs A, Brozek J, Buhl R, Bush A, Caimmi D, Calderon M, Calverley P, Camargos PA, Camuzat T, Canonica GW, Carlsen KH, Casale TB, Cazzola M, Cepeda Sarabia AM, Cesario A, Chen YZ, Chkhartishvili E, Chavannes NH, Chiron R, Chuchalin A, Chung KF, Cox L, Crooks G, Crooks MG, Cruz AA, Custovic A, Dahl R, Dahlen SE, De Blay F, Dedeu T, Deleanu D, Demoly P, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Douagui H, Dubakiene R, Eglin S, Elliot F, Emuzyte R, Fabbri L, Fink Wagner A, Fletcher M, Fokkens WJ, Fonseca J, Franco A, Frith P, Furber A, Gaga M, Garcés J, Garcia-Aymerich J, Gamkrelidze A, Gonzales-Diaz S, Gouzi F, Guzmán MA, Haahtela T, Harrison D, Hayot M, Heaney LG, Heinrich J, Hellings PW, Hooper J, Humbert M, Hyland M, Iaccarino G, Jakovenko D, Jardim JR, Jeandel C, Jenkins C, Johnston SL, Jonquet O, Joos G, Jung KS, Kalayci O, Karunanithi S, Keil T, Khaltaev N, Kolek V, Kowalski ML, Kull I, Kuna P, Kvedariene V, Le LT, Lodrup Carlsen KC, Louis R, MacNee W, Mair A, Majer I, Manning P, de Manuel Keenoy E, Masjedi MR, Melen E, Melo-Gomes E, Menzies-Gow A, Mercier G, Mercier J, Michel JP, Miculinic N, Mihaltan F, Milenkovic B, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Morgan M, N'Diaye M, Nafti S, Nekam K, Neou A, Nicod L, O'Hehir R, Ohta K, Paggiaro P, Palkonen S, Palmer S, Papadopoulos NG, Papi A, Passalacqua G, Pavord I, Pigearias B, Plavec D, Postma DS, Price D, Rabe KF, Radier Pontal F, Redon J, Rennard S, Roberts J, Robine JM, Roca J, Roche N, Rodenas F, Roggeri A, Rolland C, Rosado-Pinto J, Ryan D, Samolinski B, Sanchez-Borges M, Schünemann HJ, Sheikh A, Shields M, Siafakas N, Sibille Y, Similowski T, Small I, Sola-Morales O, Sooronbaev T, Stelmach R, Sterk PJ, Stiris T, Sud P, Tellier V, To T, Todo-Bom A, Triggiani M, Valenta R, Valero AL, Valiulis A, Valovirta E, Van Ganse E, Vandenplas O, Vasankari T, Vestbo J, Vezzani G, Viegi G, Visier L, Vogelmeier C, Vontetsianos T, Wagstaff R, Wahn U, Wallaert B, Whalley B, Wickman M, Williams DM, Wilson N, Yawn BP, Yiallouros PK, Yorgancioglu A, Yusuf OM, Zar HJ, Zhong N, Zidarn M, Zuberbier T: Integrated care pathways for airway diseases (AIRWAYS-ICP). Eur Respir J 2014; 44(2): 304-323.
366 Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, Church MK, Ensina LF, Giménez-Arnau A, Godse K, Gonçalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Abdul Latiff AH, Mathelier-Fusade P, Metz M, Saini SS, Sánchez-Borges M, Schmid-Grendelmeier P, Simons FE, Staubach P, Sussman G, Toubi E, Vena GA, Wedi B, Zhu XJ, Nast A: Methods report on the development of the 2013 revision and update of the EAACI/GA(2) LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy 2014; 69: e1–e29.
365 Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, Church MK, Ensina LF, Giménez-Arnau A, Godse K, Gonçalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Abdul Latiff AH, Mathelier-Fusade P, Metz M, Nast A, Saini SS, Sánchez-Borges M, Schmid-Grendelmeier P, Simons FE, Staubach P, Sussman G, Toubi E, Vena GA, Wedi B, Zhu XJ, Maurer M: The EAACI/GA2 LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014; DOI: 10.1111/all.12313.
364 Zuberbier T, Maurer M: Urticarial vasculitis and Schnitzler syndrome. Immunol Allergy Clin North Am 2014; 34: 141-147.
363 Haahtela T, Burbach GJ, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet J, Bousquet-Rouanet L, Bousquet PJ, Bresciani M, Bruno A, Canonica GW, Darsow U, Demoly P, Durham SR, Fokkens WJ, Giavi S, Gjomarkaj M, Gramiccioni C, Kowalski ML, Losonczy G, Orosz M, Papadopoulos NG, Stingl G, Todo-Bom A, von Mutius E, Köhli A, Wöhrl S, Järvenpää S, Kautiainen H, Petman L, Selroos O, Zuberbier T, Heinzerling LM: Clinical relevance is associated with allergen-specific wheal size in skin prick testing. Clin Exp Allergy 2014; 44(3): 407-416.
362 Zuberbier T, Worm M.: Commentary on ''dynamic analysis of histamine-mediated attenuation of acetylcholine-induced sweating via GSK3β activation''. J Invest Dermatol 2014; 134: 302-303.
361 Staevska M, Gugutkova M, Lazarova C, Kralimarkova T, Dimitrov V, Zuberbier T, Church MK, Popov TA: Night-time sedating H1 antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomised controlled trial. Br J Dermatol 2014; 171(1): 8-9.
360 Jutel M, Papadopoulos NG, Gronlund H, Hoffman HJ, Bohle B, Hellings P, Braunsthal GJ, Muraro A, Schmidt-Grendelmeyer P, Zuberbier T, Agache I: Recommendations for the allergy management in the primary care. Allergy 2014; 69: 708-18.
359 Motakis E, Guhl S, Ishizu Y, Itoh M, Kawaji H, de Hoon M, Lassmann T, Carninci P, Hayashizaki Y, Zuberbier T, Forrest AR, Babina M, FANTOM consortium: Redefinition of the human mast cell transcriptome by deep-CAGE sequencing. Blood 2014; 123(17): e58-67.
358 Werner-Busse A, Zuberbier T, Worm M: The allergic emergency - management of severe allergic reactions. J Dtsch Dermatol Ges. 2014; 12: 379-87.
357 Abajian M, Schoepke N, Altrichter S, Zuberbier T, Maurer M.: Physical urticarias and cholinergic urticaria. Immunol Allergy Clin North Am 2014; 34: 73-88.
356 Darlenski R, Kazandjieva J, Zuberbier T, Tsankov N: Chronic urticaria as a systemic disease. Clin Dermatol 2014; 32(3): 420-423.
355 Schario M, Lünnemann L,Stroux A, Reisshauer A, Zuberbier T, Blume-Peytavi U, Garcia Bartels N: Children with dry skin and atopic predisposition: Daily use of emollients in a participant-blinded, randomized, prospective trial. Skin Pharmacol Physiol 2014; 27: 208-216.
354 Worm M, Jappe U, Kleine-Tebbe J, Schäfer C, Reese I, Saloga J, Treudler R, Zuberbier T, Wassmann A, Fuchs T, Dölle S, Raithel M, Ballmer-Weber B, Niggemann B, Werfel T: Nahrungsmittelallergie infolge immunologischer Kreuzreaktivitäten mit Inhalationsallergenen. Allergo J Int 2014; 23: 1–16.
353 Karatzas K, Voukantsis D, Jaeger S, Berger U, Smith M, Brandt O, Zuberbier T, Bergmann KC: The patient’s hay-fever diary: three years of results from Germany. Aerobiologia 2014; 30(1): 1-11.
352 Makris M, Maurer M, Zuberbier, T: Pharmacotherapy of chronic spontaneous urticaria, Exp Opin Pharmaco 2013; 14(18): 2511-2519.
351 Baena-Cagnani CE, Sánchez-Borges M, Zernotti ME, Larenas-Linnemann D, Cruz AA, González-Díaz SN, Ivancevich JC, Aldrey-Palacios O, Sisul JC, Solé D, Cepeda AM, Jares EJ, Calvo Gil M, Valentin-Rostán M, Yáñez A, Gereda J, Cardona-Villa R, Rosario N, Croce VH, Bachert C, Canonica GW, Demoly P, Passalacqua G, Samolinski B, Schünemann HJ, Yorgancioglu A, Ansotegui IJ, Khaltaev N, Bedbrook A, Zuberbier T, Bousquet J. ARIA (Allergic Rhinitis and its Impact on Asthma): Achievements in 10 years and future needs in Latin America. Rev Alerg Mex 2013; 60: 184-92.
350 Burbach G, Zuberbier T: Hand-Fuß-Syndrom bei Tyrosinkinaseinhibitortherapie. Urologe 2013; 52: 1574-1578.
349 Canonica GW, Ansotegui IJ, Pawankar R, Schmid-Grendelmeier P, van Hage M, Baena-Cagnani CE, Melioli G, Nunes C, Passalacqua G, Rosenwasser L, Sampson H, Sastre J, Bousquet J, Zuberbier T, WAO-ARIA-GA²LEN Task Force: A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J 2013; 6(1): 17.
349 Canonica GW, Ansotegui IJ, Pawankar R, Schmid-Grendelmeier P, van Hage M, Baena-Cagnani CE, Melioli G, Nunes C, Passalacqua G, Rosenwasser L, Sampson H, Sastre J, Bousquet J, Zuberbier T, WAO-ARIA-GA²LEN Task Force: A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J 2013; 6(1): 17.
348 Reich-Schupke S, Alm J, Altmeyer P, Bachter D, Bayerl C, Beissert S, Bieber T, Böhmer J, Dill D, Dippel E, Dücker P, Effendy I, El Gammal S, Elsner P, Enk A, Feldmann-Böddeker I, Frank H, Gehring W, Gieler U, Goebeler M, Görge T, Gollnick H, Grabbe S, Gross G, Gudat W, Happ A, Herbst R, Hermes B, Hoff NP, John SM, Jungelhülsing M, Jünger M, Kaatz M, Kapp A, Kaufmann R, Klode J, Knaber K, König A, Krieg T, Kohl P, Kowalzick L, Lehmann P, Löffler H, Maschke J, Marsch W, Mechtel D, Mohr P, Moll I, Müller M, Nashan D, Ockenfels HM, Peter RU, Pillekamp H, Rompel R, Ruzicka T, Salfeld K, Sander C, Schaller J, Scharffetter-Kochanek K, Schuler G, Schulze HJ, Schwarz T, Splieth B, Stege H, Stolz W, Strölin A, Tran H, Tronnier M, Ulrich J, Vogt T, Wagner G, Welzel J, Willgeroth T, Wollina U, Zillikens D, Zouboulis CC, Zuberbier T, Zutt M, Stücker M: Phlebologie an deutschen Hautkliniken. Hautarzt. 2013 Sep;64(9):685-94.
347 Maurer M, Mager M, Metz M, Zuberbier T: Diagnostik und Therapie der chronischen Urtikaria - Was wird von Revision und Aktualisierung der internationalen Leitlinie erwartet? Hautarzt. 2013;64:638-643.
346 Makris M, Maurer M, Zuberbier T: Pharmacotherapy of chronic spontaneous urticaria. Expert Opin. 2013;14:2511-2512
345 Zuberbier T, Maurer M: Revision und Aktualisierung der internationalen Urtikaria Leitlinie. Der Deutsche Dermatologe 2013;8:520-521
344 Zuberbier T: Allergologie State of the Art. Kompendium Dermatologie 2013;9:19-22
343 Ohanyan T, Maurer M, Zuberbier T, Siebenhaar F: Allergien in den Griff bekommen. Der Hausarzt 2013;17:34-38.
342 Zuberbier T, Wedi B: Urtikaria. Hautarzt. 2013;64:636-637.
341 Bergmann K-C, Simoleit A, Wagener S, Mücke H-G, Werchan M, Zuberbier T: Verteilung von Pollen und Feinstaub in einem städtischen Ballungsraum am Beispiel der Großstadt Berlin. Allergo J. 2013;22:471-475.
340 Bergmann K-C, Simoleit A, Wagener S, Mücke H-G, Werchan M, Zuberbier T: The distribution of pollen and particulate matter in an urban agglomeration using the city of Berlin as an example. Allergo J. 2013;22:475-479.
339 Maurer M, Magerl M, Metz M, Zuberbier T: Neues von der internationalen Leitlinie für Diagnostik und Therapie der chronischen Urtikaria. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2013;11(10):971-979.
338 Bonini M, Bachert C, Baena-Cagnani CE, Bedbrook A, Brozek JL, Canonica GW, Cruz AA, Fokkens WJ, Gerth van Wijk R, Grouse L, Hellings PW, Howarth P, Kalayci O, Khaltaev N, Kuna P, Larenas Linnemann D, Nekam K, Palkonen S, Papadopoulos NG, Popov TA, Price D, Rosado Pinto J, Rasi G, Ryan D, Samolinski B, Scadding GK, Schünemann HJ, Thomas DM, Triggiani M, Yorgancioglu A, Yusuf OM, Zuberbier T, Pawankar R, Bousquet J, Bonini S: What we should learn from the London Olympics. Curr Opin Allergy Clin Immunol 2013;13(1):1-3.
337 Bousquet J, Zuberbier T, Canonica GW, Fokkens WJ, Gopalan G, Shekar T: Randomized controlled trial of desloratadine for persistent allergic rhinitis: correlations between symptom improvement and quality of life. Allergy Asthma Proc 2013;34(3):274-282.
336 Canonica GW, Baena-Cagnani CE, Compalati E, Bohle B, Bonini S, Bousquet J, Cox L, Fink-Wagner AH, González Díaz S, Jacobsen L, Passalacqua G, Pawankar R, Vieths S, Yusuf O, Zuberbier T: 100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco. Int Arch Allergy Immunol 2013;160(4):346-349.
335 Czaika VA, Siebenbrock J, Czekalla F, Zuberbier T, Sieber MA: Reactive oxygen species and the bacteriostatic and bactericidal effects of isoconazole nitrate. Mycoses 2013;56 Suppl 1:16-22.
334 Krause K, Mahamed A, Weller K, Metz M, Zuberbier T, Maurer M: Efficacy and safety of canakinumab in urticarial vasculitis: An open-label study. J Allergy Clin Immunol Sep 2013;132(3):751-755
333 Krause K, Spohr A, Zuberbier T, Church MK, Maurer M: Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy 2013;68(7):921-928.
332 Maurer M, Bindslev-Jensen C, Gimenez-Arnau A, Godse K, Grattan CE, Hide M, Kaplan AP, Makris M, Simons FER, Zhao Z, Zuberbier T, Church MK: Chronic idiopathic urticaria (CIU) is no longer idiopathic: time for an update. Br J Dermatol 2013;168(2):455-456.
331 Roth-Walter F, Starkl P, Zuberbier T, Hummel K, Nobauer K, Razzazi-Fazeli E, Brunner R, Pali-Schöll I, Kinkel J, Felix F, Jensen-Jarolim E, Kinaciyan T: Glutathione exposes sequential IgE-epitopes in ovomucoid relevant in persistent egg allergy. Mol Nutr Food Res 2013;57(3):536-544.
330 Weller K, Viehmann K, Brautigam M, Krause K, Siebenhaar F, Zuberbier T, Maurer M: Management of chronic spontaneous urticaria in real life--in accordance with the guidelines? A cross-sectional physician-based survey study. J Eur Acad Dermatol Venereol 2013;27(1):43-50.
329 Berger U,Karatzas K, Jaeger S, Voukantsis D, Sofiev M, Brandt O, Zuberbier T, Bergmann KC: Personalized pollen-related symptom-forecast information services for allergic rhinitis patients in Europe. Allergy. Jul 30 2013.
328 Weller K, Viehmann K, Bräutigam M, Krause K, Siebenhaar F, Zuberbier T, Maurer M: Cost-intensive, time-consuming, problematical? How physicians in private practice experience the care of urticaria patients. J Dtsch Dermatol Ges. 2013;10(5):341-7.
327 Bousquet J, Tanasescu CC, Camuzat T, Anto JM, Blasi F, Neou A, Palkonen S, Papadopoulos N G, Antunes JP, Samolinski B, Yiallouros P, Zuberbier T: Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing. Allergy 2013;68(5):555-561.
326 Zuberbier T. Classification of urticaria. IJD. 2013; 58(3):208-210.
325 Weller K, Ardelean E, Scholz E, Martus P, Zuberbier T, Maurer M. Can On-demand Non-sedating Antihistamines Improve Urticaria Symptoms? A Double-blind, Randomized, Single-dose Study. Acta Derm Venereol. 2013 Mar 27;93(2):168-74.
324 Brinkhaus B, Ortiz M, Witt C, Roll S, Linde K, Pfab F, Niggemann B, Hummelsberger J, Treszl A, Ring J, Zuberbier T, Wegscheider K, Willich N. Acupuncture in patients with seasonal allergic rhinitis. Ann Intern Med. 19 February 2013;158(4):225-234.
323 Zuberbier T: A Summary of the New International EAACI/GA²LEN/EDF/WAO Guidelines in Urticaria. World Allergy Organ J. 2012 Jan;5 Suppl 1:S1-5.
322 Guhl S, Artuc M, Zuberbier T, Babina M. Testosterone exerts selective anti-inflammatory effects on human skin mast cells in a cell subset dependent manner. Exp Dermatol. 2012 Nov;21(11):878-80.
321 Zuberbier T, Canonica GW, da Silva B. Specific immunotherapy with allergens: an important tool in the treatment of the allergic diseases. Dtsch Dermatol Ges. 2012 Dec;10(12):879-86.
320 Burbach GJ, Vajkoczy P, Zuberbier T. Celecoxib desensitization: continued temozolomide/celecoxib chemotherapy after a celecoxib-induced hypersensitivity reaction. Anti-Cancer Drugs 2012, 23:1118–1120.
319 Sánchez-Borges M, Asero R, Ansotegui IJ, Baiardini I, Bernstein JA, Canonica WG, Gower R, Kahn DA, Kaplan AP, Katelaris C, Maurer M, Park HS, Potter P, Saini S, Tassinari P, Tedeschi A, Ye YM, Zuberbier T, the WAO Scientific and Clinical Issues Council: Diagnosis and Treatment of Urticaria and Angioedema: A Worldwide perspective. WAO Position Paper. WAO Journal. November 2012.
318 Novak N, Bieber T, Hoffmann M, Fölster-Holst R, Homey B, Werfel T, Sager A, Zuberbier T. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol. 2012 Sep 1.
317 Bousquet J, Heinzerling L, Bachert C, Papadopoulos NG, Bousquet PJ, Burney PG, Canonica GW, Carlsen KH, Cox L, Haahtela T, Lodrup Carlsen KC, Price D, Samolinski B, Simons FE, Wickman M, Annesi-Maesano I, Baena-Cagnani CE, Bergmann KC, Bindslev-Jensen C, Casale TB, Chiriac A, Cruz AA, Dubakiene R, Durham SR, Fokkens WJ, Gerth-van-Wijk R, Kalayci O, Kowalski ML, Mari A, Mullol J, Nazamova-Baranova L, O'Hehir RE, Ohta K, Panzner P, Passalacqua G, Ring J, Rogala B, Romano A, Ryan D, Schmid-Grendelmeier P, Todo-Bom A, Valenta R, Woehrl S, Yusuf OM, Zuberbier T, Demoly P; Global Allergy and Asthma European Network; Allergic rhinits and its Impact on Asthma: Practical guide to skin prick tests in allergy to aeroallergens. Allergy. 2012; 67(1):18-24.
316 Bousquet J, Ansótegui I, Canonica GW, Zuberbier T, Baena-Cagnani CE, Bachert C, Cruz AA, González SN, Kuna P, Morais-Almeida M, Mullol J, Ryan DP, Sánchez-Borges M, Valiente R, Church MK: Establishing the place in therapy of bilastine in the treatment of allergic thinitis according to ARIA: evidence review. Curr Med Res Opin. 2012; 28(1):131-139.
315 Zielinski CE, Zuberbier T, Maurer M: Immunoregulation in cutaneous allergy: prevention and control. Curr Opin Allergy Clin Immunol. 2012; 12(5):498-503.
314 Krause K, Metz M, Zuberbier T, Maurer M: The role of interleukin-1 in allergy-related disorders. 2012; 477-484.
313 Zuberbier T, Werfel T: Is European legislation killing allergy diagnostic? Curr Opin Allergy Clin Immunol. 2012; 12(5):475-476.
312 Reese I, Ballmer-Weber B, Beyer K, Erdmann s, Fuchs T, Klein-Tebbe J, Klimek K, Lepp U, Henzgen M, Niggemann B, Salonga J, Schäfer C, Werfel T, Zuberbier T, Worm M: Vorgehen bei Verdacht auf Unverträglichkeit gegenüber oral aufgenommenem Histamin. Allergologie. 2012; 35(7):335-342.
311 Roth-Walter F, Starkl P, Zuberbier T, Brunner R, Pali-Schöll I, Kinkel J, Felix F, Jensen-Jarolim E, Kinaciyan T: Glutathione Exposed Sequential Epitopes of Ovomucoid Are Relevant for Persistent Egg-Allergic Patients. WAO Journal. 2012;
310 Bergmann KC, Zuberbier T: Successful Treatment of Severe Nonallergic Asthma by Omalizumab. An Observation. WAO Journal. 2012; 5: S109.
309 Weller K, Soost S, Worm M, Maurer M, Zuberbier T: Atopic dermatitis and allergic rhinitis – do co-effects in therapy exist?. J Dtsch Dermatol Ges. 2012; 10: 221–239.
308 Antó JM, Pinart M, Akdis M, Auffray C, Bachert C, Basagaña X, Carlsen KH, Guerra S, von Hertzen L, Illi S, Kauffmann F, Keil T, Kiley JP, Koppelman GH, Lupinek C, Martinez FD, Nawijn MC, Postma DS, Siroux V, Smit HA, Sterk PJ, SunyerJ, Valenta R, Valverde S, Akdis CA, Annesi-Maesano I, Ballester F, Benet M, Cambon-Thomsen A, Chatzi L, Coquet J, Demoly P, Gan W, Garcia-Aymerich J, Gimeno-Santos E, Guihenneuc-Jouyaux C, Haahtela T, Heinrich J, Herr M, Hohmann C, Jacquemin B, Just J, Kerkhof M, Kogevinas M, Kowalski ML, Lambrecht BN, Lau S, Lødrup Carlsen KC, Maier D, Momas I, Noel P, Oddie S, Palkonen S, Pin I, Porta D, Punturieri A, Rancière F, Smith RA, Stanic B, Stein RT, van de Veen W, van Oosterhout AJ, Varraso R, Wickman M, Wijmenga C, Wright J, Yaman G, Zuberbier T, Bousquet J. Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: A Mechanisms of the Development of Allergy (MeDALL) Seminar. J Allergy Clin Immunol. 2012; 129(4): 943–954.
307 Weller K, Soost S, Worm M, Maurer M, Zuberbier T. Atopische Dermatitis und allergische Rhinitis - gibt es Co-Effekte in der Therapie? J Dtsch Dermatol Ges. 2012; 4(10): 221-236.
306 Weller K, Viehmann K, Brutigam M, Krause K, Siebenhaar F, Zuberbier T, Maurer, M: Kostenintensiv, zeitaufwendig, problematisch? – Die Betreuung von Urtikariapatienten aus der Perspektive niedergelassener Ärzte. J Dtsch Dermatol Ges. 2012; 10: 341–349.
305 Zuberbier T: Chronic Urticaria. Curr Allergy Asthma Rep. 2012; 12(4): 267–272.
304 Bousquet J, Anto JM, Demoly P, Schünemann HJ, Togias A, Akdis M, Auffray C, Bachert C, Bieber T, Bousquet PJ, Carlsen KH, Casale TB, Cruz AA, Keil T, Lodrup Carlsen KC, Maurer M, Ohta K, Papadopoulos NG, Roman Rodriguez M, Samolinski B, Agache I, Andrianarisoa A, Ang CS, Annesi-Maesano I, Ballester F, Baena-Cagnani CE, Basagaña X, Bateman ED, Bel EH, Bedbrook A, Beghé B, Beji M, Ben Kheder A, Benet M, Bennoor KS, Bergmann KC, Berrissoul F, Bindslev Jensen C, Bleecker ER, Bonini S, Boner AL, Boulet LP, Brightling CE, Brozek JL, Bush A, Busse WW, Camargos PA, Canonica GW, Carr W, Cesario A, Chen YZ, Chiriac AM, Costa DJ, Cox L, Custovic A, Dahl R, Darsow U, Didi T, Dolen WK, Douagui H, Dubakiene R, El-Meziane A, Fonseca JA, Fokkens WJ, Fthenou E, Gamkrelidze A, Garcia-Aymerich J, Gerth van Wijk R, Gimeno E, Guerra S, Haahtela T, Haddad H, Hellings PW, Hellquist-Dahl B, Hohmann C, Howarth P, Hourihane JO, Humbert M, Jacquemin B, Just J, Kalayci O, Kaliner MA, Kauffmann F, Kerkhof M, Khayat G, Koffi N'goran B, Kogevinas M, Koppelman GH, Kowalski ML, Kull I, Kuna P, Larenas D, Lavi I, Le LT, Lieberman P, Lipworth B, Mahboub B, Makela MJ, Martin F, Martinez FD, Marshall GD, Mazon A, Melen E, Meltzer EO, Mihaltan F, Mohammad Y, Mohammadi A, Momas I, Morais-Almeida M, Mullol J, Muraro A, Naclerio R, Nafti S, Namazova-Baranova L, Nawijn MC, Nyembue TD, Oddie S, O'Hehir RE, Okamoto Y, Orru MP, Ozdemir C, Ouedraogo GS, Palkonen S, Panzner P, Passalacqua G, Pawankar R, Pigearias B, Pin I, Pinart M, Pison C, Popov TA, Porta D, Postma DS, Price D, Rabe KF, Ratomaharo J, Reitamo S, Rezagui D, Ring J, Roberts R, Roca J, Rogala B, Romano A, Rosado-Pinto J, Ryan D, Sanchez-Borges M, Scadding GK, Sheikh A, Simons FE, Siroux V, Schmid-Grendelmeier PD, Smit HA, Sooronbaev T, Stein RT, Sterk PJ, Sunyer J, Terreehorst I, Toskala E, Tremblay Y, Valenta R, Valeyre D, Vandenplas O, van Weel C, Vassilaki M, Varraso R, Viegi G, Wang DY, Wickman M, Williams D, Wöhrl S, Wright J, Yorgancioglu A, Yusuf OM, Zar HJ, Zernotti ME, Zidarn M, Zhong N, Zuberbier T. Severe Chronic Allergic (and Related) Diseases: A Uniform Approach - A MeDALL - GA²LEN - ARIA Position Paper. Int Arch Allergy Immunol. 2012;1;158(3): 216-231.
303 Bergmann KC, Zuberbier T, Augustin J, Mücke HG, Straff W. Klimawandel und Pollenallergie: Städte und Kommunen sollten bei der Bepflanzung des öffentlichen Raums Rücksicht auf Pollenallergiker nehmen. Allergo J. 2012;21(2): 103-108.
302 Krause K, Weller K, Stefaniak R, Wittkowski H, Altrichter S, Siebenhaar F, Zuberbier T, Maurer M. Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study. Allergy. 2012;67(7): 943-950.
301 Samolinski B, Fronczak A, Kuna P, Akdis CA, Anto JM, Bialoszewski AZ, Burney PG, Bush A, Czupryniak A, Dahl R, Flood B, Galea G, Jutel M, Kowalski ML, Palkonen S, Papadopoulos N, Raciborski F, Sienkiewicz D, Tomaszewska A, Von Mutius E, Willman D, Wlodarczyk A, Yusuf O, Zuberbier T, Bousquet J. Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union. Allergy- 2012;67(6): 726-731.
300 Olze H, Zuberbier T, Bachert C: Die chronische Rhinosinusitis in Europa - eine Zusammenfassung epidemiologischer Arbeiten von GA²LEN. Allergologie. 2012; 35(3): 110-114.
299 Yorgancioglu A, Ozdemir C, Kalayci O, Kalyocu AF, Bachert C, Baena-Cagnani CE, Casale TB, Chen YZ, Cruz AA, Demoly P, Fokkens WJ, Lodrup Carlsen KC, Mohammad Y, Mullol J, Ohta K, Papadopoulos NG, Pawankar R, Samolinski B, Schünemann HJ, Yusuf OM, Zuberbier T, Bousquet J: ARIA (Allergic rhinitis and its impact on asthma) Achievements in 10 years and future needs. Tuberk Toraks. 2012; 60(1): 92 – 97.
298 Burbach BJ, Heinzerling LM, Zuberbier T: Sensibilisierungen gegenüber inhalativen Allergenen in Europa: Ergebnisse der GA²LEN Pricktest-Studien. Allergologie. 2012; 35(3): 103 – 109.
297 Sekerel BE, Sahiner UM, Bousquet J, Demoly P, Zuberbier T, Carlsen KH, Wickman M: Practical guide to skin prick tests in allergy to aeroallergens: some concerns. Allergy. 2012; 67(3): 442 – 443.
296 Zuberbier T: Pharmacologic rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses. J Eur Acad Dermatol Venereol. 2012; 26(1): 9 – 18.
295 Zuberbier T, Aberer W, Brockow K, Grabbe J, Hamelmann E, Hartmann K, Jakob T, Maurer M, Merk HF, Ollert M, Ruëff F, Schmid-Grendelmeier P, Staubach P, Voigtmann I, Wedi B: S3-Leitlinie Urtikaria. Teil 2: Therapie der Urtikaria - deutschsprachige Version der internationalen S3-Leitlinie. Allergologie. 2011; 12. 1-22.
294 Zuberbier T, Aberer W, Brockow K, Grabbe J, Hamelmann E, Hartmann K, Jakob T, Maurer M, Merk HF, Ollert M, Ruëff F, Schmid-Grendelmeier P, Staubach P, Voigtmann I, Wedi B: S3-Leitlinie Urtikaria. Teil 1: Klassifikation und Diagnostik der Urtikaria - deutschsprachige Version der internationalen S3-Leitlinie. Allergologie. 2011; 12. 259-276.
293 Godse KV, Zawar V, Krupashankar D, Girdhar M, Kandhari S, Dhar S, Ghosh S, Rajagopalan M, Zuberbier T: Consensus statement on the management of urticaria. Indian J Dermatol. 2011; 56(5): 485 – 489.
292 Artuc M, Guhl S, Babina M, Unger T, Steckelings UM, Zuberbier T: Mast cell-derived TNF-a and histamine modify IL-6 and IL-8 expression and release from cutaneous tumor cell. Exp Dermatol. 2011; 20(12): 1020 – 1022.
291 Maurer M, Bindslev-Jensen C, Schoepke N, Zuberbier T: Effects of a Novel GA²LEN Training Program on Urticaria on the Knowledge of General Practitioners in Saudi-Arabia. WAO Journal, 2011; 4: 45 – 46.
290 Niggemann B, Beyer K, Erdmann S, Fuchs T, Klein-Tebbe J, Lepp U, Raithel M, Reese I, Saloga J, Schäfer C, Szépfalusi Z, Vieths S, Zuberbier T, Werfel T, Worm M: Standardisierung von oralen Provokationstests bei Verdacht auf Nahrungsmittelallergie. Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbands Deutscher Allergologen (ÄDA) sowie der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA). Allergologie, 2011; 34(9): 467 – 479.
289 Olze H, Zuberbier T: Comorbidities between nose and skin. Curr Opin Allergy Clin Immunol. 2011; 11(5): 457 – 463.
288 Zuberbier T, Aberer W, Brockow K, Grabbe J, Hamelmann E, Hartmann K, Jakob T, Merk H, Ollert M, Ruëff F, Schmid-Grendelmeier P, Staubach P, Voigtmann I, Wedi B, Maurer M: Therapie der Urtikaria: German language version of the international S3-guideline. Allergo J. 2011; 5: 249 – 258.
287 Zuberbier T, Aberer W, Brockow K, Grabbe J, Hamelmann E, Hartmann K, Jakob T, Merk H, Ollert M, Ruëff F, Schmid-Grendelmeier P, Staubach P, Voigtmann I, Wedi B, Maurer M: Klassifikation und Diagnostik der Urtikaria: German language version of the international S3-guideline. Allergo J. 2011; 5: 249 – 258.
286 Metz M, Doyle E, Bindslev-Jensen C, Watanabe T, Zuberbier T, Maurer M: Effects of antihistamines on innate immune responses to severe bacterial infection in mice. Int Arch Allergy Immunol. 2011; 155(4): 355 – 360.
285 Baiardini I, Braido F, Bindslev-Jensen C, Bousquet PJ, Brzoza Z, Canonica GW, Compalati E, Fiocchi A, Fokkens W, Gerth van Wijk R, Giménez-Arnau A, Godse K, Grattan C, Grob JJ, La Grutta S, Kalogeromitros D, Kocatürk E, Lombardi C, Mota-Pinto A, Ridolo E, Saini SS, Sanchez-Borges M, Senna GE, Terreehorst I, Todo Bom A, Toubi E, Bousquet J, Zuberbier T, Maurer M: Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA²LEN taskforce position paper. Allergy. 2011; 66(7): 840 – 844.
284 Maurer M, Altrichter S, Bieber T, Biedermann T, Bräutigam M, Seyfried S, Brehler R, Grabbe J, Hunzelmann N, Jakob T, Jung A, Klein-Tebbe J, Mempel M, Meurer M, Reich K, Ruëff F, Schäkel K, Sengupta K, Sieder C, Simon JC, Wedi B, Zuberbier T, Mahler V, Staubach P: Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol. 2011; 128(1): 202 – 209.
283 Chi CC, Kirtschig G, Aberer W, Gabbud JP, Lipozencic J, Kárpáti S, Haustein UF, Zuberbier T, Wojnarowska F: Evidence-based (S3) guideline on topical corticosteroids in pregnancy. Br J Dermatol. 2011; 165(5): 943 – 952.
282 Burbach G, Zuberbier T: Diagnosis of drug-induced skin reactions: a future role for computer-aided systems? Curr Opin Allergy Clin Immunol. 2011; 11(5): 451 – 456.
281 Worm M, Kostev K, Hompes S, Zuberbier T: Versorgungsprofil von Patienten mit schweren allergischen Reaktionen. Allergologie. 2011; 6: 258 – 293.
280 Novak N, Thaci D, Hoffmann M, Fölster-Holst R, Biedermann T, Homey B, Schaekel K, Stefan JA, Werfel T, Bieber T, Sager A, Zuberbier T: Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract - a new therapeutic option for patients with atopic dermatitis. Int Arch Allergy Immunol. 2011; 155(3): 252 – 256.
279 Wollenberg A, Bieber T, Dirschka T, Luger T, Meurer M, Proksch E, Schön MP, Schwarz T, Thaçi D, Zuberbier T, Werfel T: Leitlinie Periorale Dermatitis. J Dtsch Dermatol Ges. 2011; 9(5): 422 – 428.
278 Lee HH, Zuberbier T, Worm M: Sublinguale Immuntherapie Stand 2011. Hautarzt. 2011; 62: 467 – 476.
277 Hastan D, Fokkens WJ, Bachert C, Newson RB, Bislimovska J, Bockelbrink A, Bousquet PJ, Brozek G, Bruno A, Dahlén SE, Forsberg B, Gunnbjörnsdóttir M, Kasper L, Krämer U, Kowalski ML, Lange B, Lundbäck B, Salagean E, Todo-Bom A, Tomassen P, Toskala E, van Drunen CM, Bousquet J, Zuberbier T, Jarvis D, Burney P: Chronic rhinosinusitis in Europe - an underestimated disease. A GA²LEN study. Allergy. 2011; 66(9): 1216 – 1223.
276 Bousquet J, Schünemann HJ, Bousquet PJ, Bachert C, Canonica GW, Casale TB, Demoly P, Durham S, Carlsen KH, Malling HJ, Passalacqua G, Simons FE, Anto J, Baena-Cagnani CE, Bergmann KC, Bieber T, Briggs AH, Brozek J, Calderon MA, Dahl R, Devillier P, Gerth van Wijk R, Howarth P, Larenas D, Papadopoulos NG, Schmid-Grendelmeier P, Zuberbier T: How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA²LEN statement. Allergy. 2011; 66(6): 765 – 774.
275 Zuberbier T: Allergologie - State of the Art. Kompendium Dermatologie. 2011. 1: 20 – 23.
274 Brzoza Z, Badura-Brzoza J, Mlynek A, Magerl M, Biardini I, Canonica GW, Weller K, Kocatürk E, Kalogeromitros D, Zalewska-Janowska A, Zuberbier T, Maurer M: Adaptation and initial results of the Polish version of the GA²LEN Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL). J Dermatol Sci. 2011; 62: 36 – 41.
273 Guhl S, Artuc M, Neou A, Babina M, Zuberbier T: Long-Term Cultured Human Skin Mast Cells Are Suitable for Pharmacological Studies of Anti-Allergic Drugs Due To High Responsiveness to FceRI Cross-Linking. Biosci Biotechnol Biochem. 2011; 75(2): 382 – 384.
272 Bousquet J, Anto J, Auffray C, Akdis M, Cambon-Thomsen A, Keil T, Haahtela T, Lambrecht BN, Postma DS, Sunyer J, Valenta R, Akdis CA, Annesi-Maesano I, Arno A, Bachert C, Ballester F, Basagana X, Baumgartner U, Bindslev-Jensen C, Brunekreef B, Carlsen KH, Chatzi L, Crameri R, Eveno E, Forastiere F, Garcia-Aymerich J, Guerra S, Hammad H, Heinrich J, Hirsch D, Jacquemin B, Kauffmann F, Kerkhof M, Kogevinas M, Koppelman GH, Kowalski ML, Lau S, Lodrup-Carlsen KC, Lopez-Botet M, Lotvall J, Lupinek C, Maier D, Makela MJ, Martinez FD, Mestres J, Momas I, Nawijn MC, Neubauer A, Oddie S, Palkonen S, Pin I, Pison C, Rancé F, Reitamo S, Rial-Sebbag E, Salapatas M, Siroux V, Smagghe D, Torrent M, Toskala E, van Cauwenberge P, van Oosterhout AJM, Varraso R, von Hertzen L, Wickman M, Wijmenga C, Worm M, Wright J, Zuberbier T: MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy. 2011; 66(5): 5 96 – 604.
271 Bousquet P, Calderon MA, Demoly P, Larenas D, Passalacqua G, Bachert C, Brozek J, Canonica WG, Casale T, Fonseca J, Dahl R, Durham SR, Merk H, Worm M, Wahn U, Zuberbier T, Schünemann HJ, Bousquet J: The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: A Global Allergy and Asthma European Network (GA2LEN) article. J Allergy Clin Immunol. 2011; 127(1): 49 – 56.
270 Metz M, Altrichter S, Ardelean E, Keßler B, Krause K, Magerl M, Siebenhaar F, Weller K, Zuberbier T, Maurer M: Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria. Int Arch Allergy Immunol. 2011; 154: 177 – 180.
269 Heutelbeck A, Dik N, Hallier E, Zuberbier T, Bergmann KC: Testing for cattle allergy: modified diagnostic cutoff levels improve sensitivity in symptomatic claw trimmers. Int Arch Occup Environ Health. 2011; 84(2): 203 – 210.
268 Maurer, M, Weller K, Bindslev-Jensen C, Giménez-Arnau A, Bousquet P, Bousquet J, Canonica GW, Church MK, Godse KV, Grattan CE, Greaves MW, Hide M, Kalogeromitros D, Kaplan AP, Saini SS, Zhu X, Zuberbier T: Unmet Clinical needs in chronic spontaneous urticaria. A GA²LEN Task Force Report. Allergy. 2011; 66: 317 – 330.
267 Papadopoulos NG, Christodoulou I, Rohde G, Agache I, Almqvist C, Bruno A, Bonini S, Bont L, Bossios A, Bousquet J, Braido F, Brusselle G, Canonica GW, Carlsen KH, Chanez P, Fokkens WJ, Garcia-Garcia M, Gjomarkaj M, Haahtela T, Holgate ST, Johnston SL, Konstantinou G, Kowalski M, Lewandowska-Polak A, Lødrup-Carlsen K, Mäkelä M, Malkusova I, Mullol J, Nieto A, Eller E, Ozdemir C, Panzner P, Popov T, Psarras S, Roumpedaki E, Rukhadze M, Stipic-Markovic A, Todo Bom A, Toskala E, Van Cauwenberge P, Van Drunen C, Watelet JB, Xatzipsalti M, Xepapadaki P, Zuberbier T: Viruses and bacteria in acute asthma exacerbations - A GA²LEN-DARE* systematic review. Allergy. 2011; 66: 458 – 468.
266 Zuberbier T, Bachert C, Bousquet PJ, Passalacqua G, Walter Canonica G, Merk H, Worm M, Wahn U, Bousquet J: GA²LEN / EAACI Pocket guide for allergene-specific immunotherapy for allergic rhinitis and asthma. Allergy. 2010; 65: 1525 – 1530.
265 Wollenberg A, Bieber T, Dirschka T, Luger T, Meurer M, Proksch E, Schön MP, Schwarz T, Thaçi D, Zuberbier T, Werfel T: Guideline Perioral dermatitis. J Dtsch Dermatol Ges. 2010; 5(9): 422 – 427.
264 Bousquet J, Mantzouranis E, Cruz A, Ai¨t-Khaled N,Baena-Cagnani C, Bleecker E, Brightling C, Burney P, Bush C, Busse W,Casale T, Chan-Yeung M, Chen R,Chowdhury B, Chung KF, Dahl R, Drazen J, Fabbri LM, Holgate S, Kauffmann F, Haahtela T,Khaltaev N, Kiley JP, Masjedi MR, Mohammad Y, O’Byrne P, Partridge M, Rabe KF, Togias A, van Weel C, Wenzel S, Zhong N, Zuberbier T: Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol. 2010; 126(5): 926 – 938.
263 Bousquet J, Schünemann HJ, Zuberbier T, Bachert C, Baena-Cagnani CE, Bousquet PJ, Brozek J, Canonica W, Casale TB, Demoly P, van Wijk G, Ohta K, Bateman ED, Calderon M, Cruz M, Dolen WK, Haughney J, Lockey JF, Lö tvall J, O’Byrne P, Spanger O, Togias A, Bonini S, Boulet LP, Camargos P, Carlsen KH, Chavannes NH, Delgado L, Durham SR, Fokkens WJ, Fonseca J, Haahtela T, Kalayci O, Kowalski ML, Larenas-Linnemann D, Li J, Mohammad Y, Mullol J, Naclerio R, O’Hehir RE, Papadopoulos N, Passalacqua G, Rabe KF, Pawankar R, Ryan D, Samolinski B, Simons FER, Valovirta E, Yorgancioglu A, Yusuf OM, Agache I, Ait-Khaled I, Annesi-Maesano I, Beghe B, Ben Kheder A, Blaiss MS, Boakye DA, Bouchard J, Burney PG, Busse WW, Chan-Yeung M, Chen Y, Chuchalin AG, Costa DJ, Custovic A, Dahl R, Denburg J, Douagui H, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Kaliner MA, Keith PK, Kim YY, Klossek JM, Kuna P, Le LT, Lemiere C, Lipworth B, Mahboub B, Malo L, Marshall GD, Mavale-Manuel S, Meltzer EO, Morais-Almeida M, Motala C, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Ouedraogo S, Palkonen S, Popov TA, Price D, Rosado-Pinto J, Scadding GK, Sooronbaev TM, Stoloff SW, Toskala E, van Cauwenberge P, Vandenplas O, van Weel C, Viegi G, Virchow JC, Wang DY, Wickman M, Williams D, Yawn BP, Zar HJ, Zernotti M, Zhong N: Development and implementation of guidelines in allergic rhinitis - an ARIA-GA2LEN paper. Allergy. 2010; 65(10): 1212 – 1221.
262 Bousquet JP, Bachert C, Canonica GW, Casale TB, Mullol J, Klossek JM, Zuberbier T, Bousquet J: Uncontrolled allergic rhinitis during treatment and its impact on quality-of-life. A cluster randomized trial. J Allergy Clin Immunol. 2010; 126(3): 666 – 668.e 1 – 5.
26 Maurer M, Altrichter S, Ardelean E, Krause K, Magerl M, Metz M, Siebenhaar F, Weller K, Zuberbier T: Therapeutische Alternativen bei Antihistamintherapie-refraktärer Urtikaria. Hautarzt. 2010; 9: 765 – 769.
260 Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica W, Casale T, van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ: Allergic Rhinitis and its impact on Asthma (ARIA)-guidelines 2010 Revision. J Allergy Clin Immunol. 2010; 126(3): 466 – 476.
259 Wedi B, Zuberbier T: Update Urtikaria. Hautarzt. 2010; 61: 735 – 736.
258 Vieira dos Santos R, Magerl M, Martus P, Zuberbier T, Church MK, Maurer M: Topical Sodium Cromoglicate Relieves Allergen- and Histamine-Induced Dermal pruritus. Br J Dermatol. 2010; 162: 674 – 676.
257 Krause K, Ardelean E, Keßler B, Magerl M, Metz M, Siebenhaar F, Weller K, Worm M, Zuberbier T, Maurer M: Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy. Allergy. 2010; 65: 1493 – 1494.
256 Zuberbier T: Allergologie - State-of-the-art. Kompendium Dermatologie. 2010; 6(1): 20 – 22.
255 Baiardini I, Bousquet PJ, Brzoza Z, Canonica GW, Compalati E, Fiocchi A, Fokkens W, van Wijk RG, La Grutta S, Lombardi C, Maurer M, Pinto AM, Ridolo E, Senna GE, Terreehorst I, Bom AT, Bousquet J, Zuberbier T, Braido F, Global Allergy and Asthma Network: Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA²LEN taskforce position paper. Allergy. 2010; 65(3): 290 – 295.
254 Braido F, Bousquet PJ, Brzoza Z, Canonica GW, Compalati E, Fiocchi A, Fokkens W, Gerth van Wijk R, La Grutta S, Lombardi C, Maurer M, Pinto AM, Ridolo E, Senna GE, Terreehorst I, Todo Bom A, Bousquet J, Zuberbier T. Baiardini I: Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA²LEN taskforce position paper. Allergy. 2010; 65(8): 959 – 968.
253 Alsowaidi S, Abdulle A, Shehab A, Zuberbier T, Bernsen R: Allergic rhinitis: prevalence and possible risk factors in a gulf arab population. Allergy. 2010; 65: 208 – 212.
252 Bousquet J, Bachert C, Canonica GW, Mullol J, Van Cauwenberge P, Bindslev Jensen C, Fokkens WJ, Ring J, Keith P, Gopalan G, Lorber R, Zuberbier T: The ACCEPT-2 Study Group. Efficacy of desloratadine in persistent allergic rhinitis - a GA²LEN study. Int Arch Allergy Immunol. 2010; 153: 395 – 402.
251 Guhl S, Babina M, Neou A, Zuberbier T, Artuc M: Mast cell lines HMC-1 and LAD2 in comparison with mature human skin mast cells – drastically reduced levels of tryptase and chymase in mast cell lines. Exp Dermatol. 2010; 19: 845 – 847.
250 Scutaru C, Quarcoo D, Sakr M, Shami A, Al-Mutawakel K, Vitzthum K, Fischer TC, Zuberbier T, Groneberg-Kloft B: Density-equalizing mapping and scientometric benchmarking of European allergy research. J Occup Med Toxicol. 2010; 5(2): 1 – 8.
249 Lepp U, Ballmer-Weber B, Beyer K, Erdmann S, Fuchs T, Henzgen M, Heratizadeh A, Huttegger I, Jappe U, Klein-Tebbe J, Niggemann B, Raithel M, Reese I, Saloga J, Schäfer C, Szépfalusi Z, Vieths S, Werfel T, Zuberbier T, Worm M, Arbeitsgruppe "Nahrungsmittelallergie" der DGAKI: Therapiemöglichkeiten bei der IgE-vermittelten Nahrungsmittel-Allergie. Allergo J. 2010; 3(19): 187 – 195.
248 Bockelbrink A., Aurich F, Reich A, Willich Stefan N, Zuberbier T, Keil T: Brandenburger Asthma und Allergiestudie (BASAL) - erste Ergebnisse. Allergo J. 2010; 3(19): 185 – 186.
247 Bachert C, Kuna T, Zuberbier T: Bilastine in allergic rhinoconjunctivitis and urticaria. Allergy. 2010; 65(93): 1 – 13.
246 Zuberbier T, Balke M, Worm M, Edenharter G, Maurer M: Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol. 2010; 35(8): 869 – 873.
245 Krause K, Zuberbier T, Maurer M: Modern approaches to the diagnosis and treatment of cold contact urticaria. Curr Allergy Asthma Rep. 2010; 10(4): 243 – 249.
244 Heinzerling L, Burbach G, van Cauwenberge P, Papageorgiou P, Carlsen KH, Carlsen KC, Zuberbier T: Establishing a standardized quality management system for the European Health Network GA²LEN. Allergy. 2010; 65(6): 743 – 752.
243 Kröpfl L, Maurer M, Zuberbier T: Treatment strategies in urticaria. Expert Opinion in Pharmacotherapy. 2010; 11(9): 1445 – 1450.
242 Babina M, Kirn F, Hoser D, Ernst D, Rohde W, Zuberbier T, Worm M: Tamoxifen counteracts the allergic immune response and improves allergen-induced dermatitis in mice. Clin Exp Allergy. 2010; 40: 1256 – 1265.
241 Dölle S, Hoser D, Rasche C, Loddenkemper C, Maurer M, Zuberbier T, Worm M: Long-term reduction in local inflammation by a lipid raft molecule in atopic dermatitis. Allergy. 2010; 65(9): 1158 – 1165.
240 Wanner R, Sonnenburg A, Quatchadze M, Schreiner M, Peiser M, Zuberbier T, Stahlmann R: Classification of sensitizing and irritative potential in a combined in-vitro assay. Toxicol Appl Pharmacol. 2010; 245(2): 211 – 218.
239 Church MK, Maurer M, Bindslev-Jensen C, van Cauwenberge P, Bousquet J, Holgate ST, Simons FER, Zuberbier T: Risk of first-generation H1-antihistamines: a GA²LEN position paper. Allergy. 2010; 65: 459 – 466.
238 Soost S, Zuberbier T, Zuberbier M, Worm M: Occupational contact dermatitis from ninhydrin in a police officer. Contact Dermatitis. 2010; 62(1): 59 – 60.
237 Alsowaidi S, Abdulle A, Bernsen R, Zuberbier T: Allergic Rhinitis and Asthma: A Large Cross Sectional Study in the United Arab Emirates. Int Arch Allergy Immunol. 2010; 65(2): 274 – 279.
236 Magerl M, Pisarevskaja D, Scheufele R, Zuberbier T, Maurer M: Effects of a pseudoallergen-free diet on chronic spontaneous urticaria: a prospective trial. Allergy. 2010; 65(1): 78 – 83.
235 Rompe F, Artuc M, Hallenberg A, Alterman M, Ströder K, Thöne-Reineke C, Reichenbach A, Schacherl J, Dahlöf, J, Bader M, Alenina M, Schwaninger M, Zuberbier T, Funke-Kaiser H, Schmid C, Schunck WH, Unger T, Steckeling U: Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of Nuclear Factor kB. Hypertension. 2010; 55(4): 1 – 8.
234 Zuberbier T, Oanta A, Bogacka E, Medina I, Wesel F, Uhl P, Antépara I, Jáuregui I, Valiente R: The Balastine International Working Group. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo- controlled study. Allergy. 2010; 65: 516 – 528.
233 Konstantinou GN, Bousquet JP, Zuberbier T, Papadopoulos NG: The longest wheal diameter is the optimal measurement for the evaluation of skin prick tests. Int Arch Allergy Immunol. 2010; 151: 343 – 345.
232 Krause K, Metz M, Zuberbier T, Maurer M, Magerl M: Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant. J Dtsch Dermatol Ges. 2010; 8(4): 272 – 274.
231 Gjomarkaj M, Pace E, Canonica GW, Bonini S, Ricci G, Burney P, Zuberbier T, Van Cauwenberge P, Bousquet J: GA²LEN (Global .Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases [article in italian]. Minverva Med. 2009; 100(6): 525 – 534.
230 Mlynek A, Magerl M, Siebenhaar F, Weller K, Vieira dos Santos R, Zuberbier T, Zalewska A, Maurer M: Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria. Br J Dermatol. 2009; 162: 198 – 200.
229 Wöhrl S, Radon K, Ring J, Moritz K, Akdis C, Burney P, Van Cauwenberge P, Bousquet J, Zuberbier T: GA2LEN (Global Allergy and Asthma European Network), the perspective of the German speaking centers. Wien Klin Wochenschr. 2009; 121(17-18): 589 – 597.
228 Bousquet J, Kauffmann F, Demoly P, Leynaert B, Bousquet PJ, Demenais F, Lenzen G, Burney PG, Zuberbier T, Van Cauwenberge P: GA²LEN (Global Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases. Rev Mal Respir. 2009; 26(6): 577 – 586.
227 Bousquet PJ, Burbach G, Heinzerling LM, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet-Rouanet L, Demoly P, Bresciani M, Bruno A, Gjomarkaj M, Canonica GW, Darsow U, Durham S, Fokkens WJ, Giavi S, Gramiccioni C, Haahtela T, Kowalski ML, Magyar P, Muraközi G, Orosz M, Röhnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wöhrl S, Bousquet J, Zuberbier T: GA²LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients. Allergy. 2009; 64: 1656 – 1662.
226 Burbach GJ, Heinzerling L, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet P, Bousquet-Rouanet L, Bousquet PJ, Bresciani M, Bruno A, Burney P, Canonica GW, Darsow U, Demoly P, Durham S, Fokkens WJ, Giavi S, Gjomarkaj M, Gramiccioni C, Haahtela T, Kowalski ML, Magyar P, Muraközi G, Orosz M, Papadopoulos NG, Röhnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wöhrl S, Zuberbier T: GA²LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy. 2009; 64(10): 1507 – 1515.
225 Heinzerling L, Burbach GJ, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet P, Bousquet-Rouanet L, Bousquet PJ, Bresciani M, Bruno A, Burney P, Canonica GW, Darsow U, Demoly P, Durham S, Fokkens WJ, Giavi S, Gjomarkaj M, Gramiccioni C, Haahtela T, Kowalski ML, Magyar P, Muraközi G, Orosz M, Papadopoulos NG, Röhnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wöhrl S, Zuberbier T: GA²LEN skin test study I: GA²LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy. 2009; 64(10): 1498 – 1506.
224 Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK, Giménez-Arnau A, Grattan CEH, Kapp A, Maurer M, Merk HF, Rogala B, Saini S, Sánchez-Borges M, Schmid-Grendelmeier P, Schünemann H, Staubach P, Vena GA, Wedi B: EAACI/GA²LEN/EDF/WAO guideline: management of urticaria. Allergy. 2009; 64(10): 1427 – 1443.
223 Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK, Giménez-Arnau A, Grattan CEH, Kapp A, Merk HF, Rogala B, Saini S, Sánchez-Borges M, Schmid-Grendelmeier P, Schünemann H, Staubach P, Vena GA, Wedi B, Maurer M: EAACI/GA²LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy. 2009; 64(10): 1417 – 1426.
222 Bousquet J, Bachert C, Canonica GW, Casale TB, Cruz AA, Lockey RJ, Zuberbier T: Unmet neHrsg in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol. 2009; 124(3): 428 – 433.
221 Bousquet P, Cox L, Durham S, Nelson H, Passalacqua G, Ryan DP, Brozek JL, Compalati E, Dahl R, Delgado L, Gerth van Wijk R, Gower RG, Ledford DK, Rosario Filho N, Schunemann H, Valovirta EJ, Yusuf OM, Zuberbier T: Sub-lingual immunotherapy: World Allergy Organization position paper 2009. Allergy. 2009; 64: 1 – 59.
220 Canonica GW, Bousquet P, Cox LS, Durham SR, Nelson HS, Passalacqua G, Ryan DP, Brozek JL, Compalati E, Dahl R, Delgado L, Gerth van Wijk R, Gower RG, Ledford DK, Rosario Filho N, Schunemann H, Valovirta EJ, Yusuf OM, Zuberbier T: Sub-lingual immunotherapy: World Allergy Organization position paper 2009 [Anmerkung: Parallel Publikation der Leitlinie durch Weltallergie Organisation (WAO) und der Europäischen Akademie (EAACI)]. WAO Journal. 2009; 64 Suppl 91: 233 – 281.
219 Bousquet PJ, Brozek J, Bachert C, Bieber T, Burney P, Calderon M, Canonica GW, Compalati E, Daures JP, Delgado L, Demoly P, Dahl R, Durham SR, Kowalski ML, Malling HJ, Merk H, Papadopoulos N, Passalacqua G, Simon HU, Worm M, Wahn U, Zuberbier T, Bousquet J: The CONSORT statement checklist in allergen-specific immunotherapy - A GA²LEN paper. Allergy. 2009; 64(12): 1737 – 1745.
218 Bousquet J, Bachert C, Canonica GW, Mullol J, Cauwenberge P, Bindslev-Jensen C, Fokkens W, Ring J, Keit P, Lorber R, Zuberbier T: Efficacy of desloratadine in persitent allergic rhinitis: a GA²LEN study. Int Arch Allergy Immunol. 2010; 153(4): 395 – 402.
217 Mlynek A, Magerl M, Hanna M, Lhachimi L, Bairdini I, Canonica GW, Brzoza Z, Kasperska-Zajac A, Rogala B, Zalewska-Janowska A, Zuberbier T, Maurer M: The German version of the chronic urticaria qualtiy-of-life questionnaire: factor analysis, validation, and initial clinical findings. Allergy. 2009; 64: 927 – 936.
216 Klein-Tebbe J, Reese I, Ballmer-Weber BK, Beyer K, Erdmann S, Fuchs T, Henzgen M, Heratizadeh Am Huttegger I, Jäger L, Jaape U, Lepp U, Niggemann B, Raithel M, Saloga J, Szepfalusi Z, Zuberbier T, Werfel T, Vieths S, Worm M: Keine Empfehlung für IgG- und IgG4-Bestimmungen gegen Nahrungsmittel. Allergo J. 2009; 18: 267 – 273.
215 Bousquet J, Burney PG, Zuberbier T, Van Cauwenberge C, Akdis CA, Bindslev-Jensen C, Bonini S, Fokkens WJ, Kauffmann F, Kowalski ML, Lodrup-Carlsen K, Mullol J, Nizankowska-Mogilnicka E, Papadopoulus N, Toskala W, Wickman M, Anto J, Auvergne N, Bachert C, Bousquet JP, Brunekreef B, Canonica GW, Carlsen KH, Gjomarkaj M, Haahtela T, Howarth P, Lenzene G, Lotvall J, Radon K, Ring J, Salapatas M, Schünemann HJ, Szczecklik A, Todo-Bom A, Vilavirta E, von Mutius E, Zock JP: GA²LEN (Global Allergy and European Asthma Network) addresses the allergy and asthma 'epidemic'. Allergy; 2009; 64: 969 – 977.
214 Werfel T, Erdmann S, Fuchs T, Henzgen M, Klein-Tebbe J, Lepp U, Niggemann B, Raithel M, Reese I, Saloga J, Vieluf I, Vieths S, Zuberbier T: Approach to suspected food allergy in atopic dermatitis. Guideline of the Task Force on Food Allergy of the German Society of Allergology and Clinical Immunology (DGAKI) and the Medical Association of German Allergologists (ADA) and the German Society of Pediatric Allergology (GPA). J Dtsch Dermatol Ges. 2009; 7: 265 – 272.
213 Bachert C, van Bruaene N, Toskala E, Zhang N, Olze H, Scadding G, van Drunen CM, Mullol J, Cardell L, Gavaert P, van Zele T, Claeys S, Halldén C, Kostamo K, Foerster U, Kowalski M, Bieniek K, Olszewska-Ziaber A, Nizankowska-Moglinicka E, Szczeklik A, Swierczynka M, Arcimowicz M, Lund V, Fokkens W, Zuberbier T, Akdis C, Canonica GW, van Cauwenberge P, Burney P, Bousquet J: Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis - a GA²LEN study. Allergy; 2009; 64: 520 – 533.
212 Soost S, Leynaert B, Almquist C, Edenharter G, Zuberbier T, Worm M: Risk factors of adverse reaction to food in German adults. Clin Exp Allergy. 2009; 1 – 9.
211 Zuberbier T, Worm M: Die Haut zeigt, ob das Essen krank macht. Der Deutsche Dermatologe. 2009; 4: 1 – 3.
210 Bousquet JP, Demoly P, Romano A, Aberer W, Bircher A, Blanca M, Brockow K, Pichler W, Torres MJ, Terreehoert I, Arnoux B, Atanaskovic-Markovic M, Barbaud A, Bijl A, Bonadonna P, Burney P, Caimmi S, Canonica GW, Cernadas J, Dahlen B, Daures JP, Fernandesz J, Gomes E, Gueant JL, Kowalski ML, Kvedariene V, Mertes PM, Martins P, Nizankowska-Mogilnicka E, Papadopoulos N, Ponvert C, Pirmohamed M, Ring J, Salapatas M, Sanz ML, Szczeklik A, Van Ganse E, De Weck AL, Zuberbier T, Merk HF, Sachs B, Sidoroff A: Pharmacovigilance of drug allergy and hypersensitivity using the ENDA–DAHD database and the GA2LEN platform. The Galenda project. Allergy. 2009; 64(2): 194 – 203.
209 Burbach GJ, Heinzerling LM, Röhnelt C, Bergmann KC, Zuberbier T: Ragweed sensitization in Europe - GA²LEN study suggests increasing prevalence. Allergy. 2009; 64(4): 664 – 665.
208 Maurer M, Ortonne JP, Zuberbier T: Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation. Br J Dermatol. 2009; 160: 633 – 641.
207 Klein-Tebbe J, Ballmer-Weber BK, Erdmann S, Fuchs T, Klein-Tebbe J, Lepp U, Niggemann B, Raithel M, Reese I, Saloga J, Vieths S, Zuberbier T, Werfel T: In-vitro-Diagnostik und molekulare Grundlagen von IgE-vermittelten Nahrungsmittelallergien. Allergo J. 2009; 18: 132 – 146.
206 Worm M, Fiedler EM, Dölle S, Schink T, Hemmer W, Jarisch R, Zuberbier T: Exogenous Histamine Aggravates Eczema in a Subgroup of Patients with Atopic Dermatitis. Acta Derm Venereol. 2009; 89: 52 – 56.
205 Bousquet J, Bachert C, Canonica GW, Mullol J, Cauwenberge P, Bindslev-Jensen C, Fokkens W, Ring J, Keit P, Lorber R, Zuberbier T: Efficacy of desloratadine in intermittent allergic rhinitis - A GA²LEN study. Allergy. 2009; 64(10): 1516 – 1523.
204 Siebenhaar F, Degener F, Zuberbier T, Martus P, Maurer M: High-dose Desloratadine Decreases Wheal Volume and Improves Cold Provocation Thresholds as Compared with Standard Dose Treatment in Patients with Acquired Cold Urticaria: A Randomized, Placebo-Controlled, Crossover Study. J Allergy Clin Immunol. 2009; 123(3): 672 – 679.
203 Milovanovic M, Heine G, Zuberbier T, Worm M: Allergen extract-induced interleukin-10 in human memory B cells inhibits IgE production. Clin Exp Allergy. 2009; 39(5): 671 – 678.
202 Magerl M, Schmolke J, Metz M, Zuberbier T, Siebenhaar F, Maurer M: Prevention of signs and symptoms of dermographic urticaria by single dose ebastine 20 mg. Clin Exp Dermatol. 2009; 34: 137 – 140.
201 Weller K, Artuc M, Jennings G, Friedrichson T, Guhl S, Vieira dos Santos R, Sünder C, Zuberbier T, Maurer M: Miltefosine inhibits human mast cell activation and mediator release both in vitro and in vivo. J Invest Dermatol. 2009; 129(2): 496 – 498.
200 Maurer M, Ortonne JP, Zuberbier T: Chronic urticaria: An internet survey on Health Behaviors, Symptom Patterns, and Treatment NeHrsg in European Adult Patients. Br J Dermatol. 2009; 160: 663 – 641.
199 Reese I, Zuberbier T, Bunselmeyer B, Erdmann S, Henzgen M, Fuchs T, Jäger L, Klein-Tebbe J, Lepp U, Niggemann B, Raithel M, Saloga J, Viehts S, Werfel T: Diagnostic approach for suspected pseudoallergic reaction to food ingredients. J Dtsch Dermatol Ges. 2009; 7(1): 70 – 77.
198 Mrabet-Dahbi S, Metz M, Zuberbier T, Maurer M: Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp Dermatol. 2009; 18(5): 437 – 444.
197 Henzgen M, Vieths S, Reese I, Erdmann S, Fuchs T, Jäger L, Klein-Tebbe J, Lepp U, Niggemann B, Saloga J, Vieluf I, Zuberbier T, Werfel T: Food allergies caused by immunological cross reaction. Laboratoriums Medizin. 2008; 32(6): 438 – 449.
196 Henzgen M, Ballmer-Weber BK, Erdmann S, Fuchs T, Klein-Tebbe J, Lepp U, Niggemann B, Raithel M, Reese I, Saloga J, Vieths S, Zuberbier T, Werfel T: Skin testing with food allergens: Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), the Physicians' Association of German Allergologists (ÄDA) and the Society of Pediatric Allergology (GPA) together with the Swiss Society of Allergology. J Dtsch Dermatol Ges. 2008; 6: 983 – 988.
195 Worm M, Olze H, Zuberbier T: Moderne Behandlung der allergischen Rhinitis. Allergo J. 2008; 1 – 5.
194 Worm M, Hompes S, Hompes S, Vogel N, Kirschbaum J, Zuberbier T: Care of anaphylaxis among practicing doctors. Allergy. 2008; 63(11): 1562 – 1563.
193 Worm M, Hompes S, Fiedler EM, Illner AK, Zuberbier T, Vieths S: Impact of native, heat processed and encapsulated hazelnuts on the allergic response in hazelnut allergic patients. Clin Exp Allergy. 2008; 39: 159 – 166.
192 Werfel T, Fuchs T, Reese I, Erdmann S, Henzgen M, Klein-Tebbe J, Lepp U, Niggemann B, Saloga J, Vieluf I, Vieths S, Zuberbier T: Vorgehen bei vermuteter Nahrungsmittelallergie bei atopischer Dermatitis. Allergo J. 2008; 31(8): 333 – 342.
191 Zuberbier T: Nahrungsmittelallergien - Epidemiologie in Berlin. Allergologie. 2008; 31(7): 264 – 273.
190 Baiardini I, Braido F, Brandi F, Tarantint F, Porcu A, Bonini S, Bousquet JP, Zuberbier T, Demoly P, Canonica GW: The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA²LEN review. Allergy. 2008; 63(8): 1015 – 1030.
189 Bousquet J, Reid J, van Weel C, Baena Cagnani C, Canonica GW, Demoly P, Denburg J, Fokkens WJ, Grouse L, Mullol K, Ohta K, Schermer T, Valovirta E, Zhong N, Zuberbier T: Allergic rhinitis management pocket reference 2008. Allergy. 2008; 63(8): 997 – 1004.
188 Güzelby O, Ardelean E, Magerl M, Metz M, Zuberbier T, Maurer M: Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy. 2008; 63(11): 1563 – 1565.
187 Bachert C, Zuberbier T, Klimek L, Khaltaev N, Bousquet J: Allergic rhinitis and its importance for asthma: Update (ARIA2008). An inventary from German viewpoint. Allergologie. 2008; 31(5):159 – 164.
186 Zuberbier T, Maurer M, Augustin M: Use of topical steroids is largely restricted by irrational emotional concerns in both patients and physicians. Allergy. 2008; 63(11): 1560 – 1561.
185 Bousquet J, Fookens W, Burney P, Durham SR, Bachert C, Akdis CA, Canonica GW, Dahlen SE, Zuberbier T, Bieber T, Bonini S, Bousquet PJ, Brozek JL, Cardell LO, Crameri R, Custovic A, Demoly P, van Wijk RG, Gjomarkaij M, Holland C, Howarth P, Johnston SL, Kauffmann F, Kowalski ML, Lambrecht B, Lehmann S, Leynaert B, Lodrup-Carlsen K, Mullol J, Niggemann B, Nizankowska-Mogilnicka E, Papadopoulos N, Passalacquua G, Schünemann HJ, Simon HU, Todo-Bom A, Toskala E, Valenta R, Wickman M, Zock JP: Important questions in allergy and related diseases: Nonallergic rhinitis: a GA²LEN paper. Allergy. 2008; 63(7): 842 -853.
184 Schreiner M, Peiser M, Briechle D, Stahlmann R, Zuberbier T, Wanner R: A new dendritic cell type suitable as sentinel of contact allergens. Toxicology. 2008; 249(2-3): 146 - 152.
183 Przybilla B, Aberer W, Bircher AJ, Brehler R, Brockow K, Dickel H, Fuchs T, Hertl M, Mockenhaupt M, Pfaar O, Ring J, Sachs B, Vieluf D, Wedi B, Worm M, Zuberbier T, Merk HF: Allergological approach to drug hypersensitivity reactions. Allergologie. 2008; 31(4): 153 – 158.
182 Schwarz T, Kreiselmaier I, Bieber T, Thaci D, Simon JC, Meurer M, Werfel T, Zuberbier T, Luger TA, Wollenberger A, Bräutigam M: A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis. J Am Acad Dermatol. 2008; 59(1): 34 – 40.
181 Shaheen S, Potts J, Gnatiuc L, Kowalski ML, Hoos G, van Zele T, van Durme Y, de Rudder I, Wöhrl S, Godnic-Cvar J, Skadhauge L, Thomsen G, Zuberbier T, Bergmann KC, Heinzerling L, Gjomarkaj M, Bruno A, Pace E, Bonini S, Fokkens W, Weersink EJM, Loureiro C, Villanueva CM, Sanjuas C, Zock JP, Janson C, Burney P: The relation between paracetamol use and asthma: a European case-control study. Eur Respir J. 2008; 32(5): 1231 – 1236.
180 Zuberbier T, Bräutigam M: Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease. J Eur Acad Dermatol Venereol. 2008; 22(6): 718 – 721.
179 Mlynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M: How to assess disease activity in patients with chronic urticaria? Allergy. 2008; 63(6): 777 – 780.
178 Zuberbier T: Allergologie - State-of-the-art. Kompendium Dermatologie. 2008.
177 Burney P, Potts J, Makowska J, Kowlaski M, Philipps J, Gnatiuc L, Shaheen S, Joos G, van Cauwenberge P, van Zele T, Verbruggen K, van Durme Y, Derudder I, Wohrl S, Godnic-Cvar J, Salameh B, Skadhauge L, Thomsen G, Zuberbier T, Bergmann KC, Heinzerling L, Renz H, Al-Fakhri N, Kosche B, Hildenberg A, Papadopoulus NG, Xepapadaki P, Zannikos K, Gjomarkaj M, Bruno A, Pace E, Bonini S, Bresciani M, Gramiccioni C, Fokkens W, Weersink EJM, Carlsen KH, Bakkeheim E, Loureiro C, Villanueva CM, Sanjuas C, Zock JP, Lundback B, Janson C: A case-control study of the relation between plasma selenium and asthma in European populations: a GA²LEN project. Allergy; 2008; 63(7): 865 – 871.
176 Zuberbier T: Pollenallergie in Europa. Ärztliche Praxis. 2008; 1-7.
175 Przybilla B, Aberer W, Bircher AJ, Brehler R, Brockow K, Dickel H, Fuchs T, Hertl M, Mockenhaupt M, Pfaar O, Ring J, Sachs B, Vieluf D, Wedi B, Worm M, Zuberbier T, Merk HF: Allergological approach to drug hypersensitivity reaction. Allergo J. 2008; 17(1): 90 – 94.
174 Przybilla B, Aberer W, Bircher AJ, Brehler R, Brockow K, Dickel H, Fuchs T, Hertl M, Mockenhaupt M, Pfaar O, Ring J, Sachs B, Vieluf D, Wedi B, Worm M, Zuberbier T, Merk HF: Allergolocial approach to drug hypersensivity reactions. J Dtsch Dermatol Ges. 2008; 6(3): 240 – 243.
173 Bousquet J, Bieber T, Fokkens W, Kowalski ML, Humbert M, Niggemann B, Simon HU, Burney P, van Cauwenberge P, Zuberbier T, Aktis CA, Demoly P: Important questions in allergy: novel research areas. Allergy. 2008; 63(2): 143 – 147.
172 Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aït-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D, World Health Organization, GA²LEN, AllerGen: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA²LEN and AllerGen). Allergy. 2008; 63(86): 8 – 160.
171 Baiardini I, Braido F, Tarantint F, Porcu A, Bonini S, Bousquet JP, Zuberbier T, Demoly P, Canonica GW: ARIA suggested drugs for allergic rhinitis: what impact on quality of life? A GA²LEN Review. Allergy. 2008; 63(6): 660 – 669.
170 Ryan D, van Weel C, Bousquet J, Toskala E, Ahlstedt S, Palkonen S, van den Nieuwenhof L, Zuberbier T, Wickman M, Fokkens W: Primary care: the cornerstone of diagnosis of allergic rhinitis. Allergy. 2008; 63(8): 981 – 989.
169 Heinzerling L, Raile K, Rochlitz H, Zuberbier T, Worm M: Insulin allergy: Clinical manifestations and management strategies. Allergy. 2008; 63(2): 148 – 155.
168 Brozek JL, Baena-Cagnani CE, Bonini S, Canonica GW, Rasi G, van Wijk RG, Zuberbier T, Guyatt G, Bousquet J, Schünemann HJ: Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy. 2008; 63(1): 38 – 46.
167 Metz M, Bergmann P, Zuberbier T, Maurer M: Successful treatment of cholinergic urticaria with anti-IgE therapy. Allergy. 2008; 63(2): 247 – 249.
166 Magerl M, Lammel V, Siebenhaar F, Zuberbier T, Metz M, Maurer M: Nonpathogenic commensal E. coli bacteria can inhibit degranulation of mast cell. Exp Dermatol. 2008; 17: 427 – 435.
165 Heine G, Niesner U, Chang HD, Steinmeyer A, Zügel U, Zuberbier T, Radbruch A, Worm M: 1,25-dihydroxyvitamin D3 promotes interleukin-10 production in human B cells. Eur J Immunol. 2008; 38(8): 2010 – 2018.
164 Schreiner M, Peiser M, Briechle D, Stahlmann R, Zuberbier T, Wanner R: A loose-fit coculture of activated keratinocytes and dendritic cell-related cells for prediction of sensitizing potential. Allergy. 2007; 62(12): 1419 – 1428.
163 Lee H.-H, Zuberbier T, Worm M: Treatment of atopic dermatitis with pimecrolimus - Impact on quality of life. Ther Clin Risk Manag. 2007; 3(6): 1021 – 1026.
162 Bussmann C, Maintz L, Hart J, Allam JP, Vrtalaw S, Chenw KW, Bieberk T, Thomasz WR, Valentaw R, Zuberbier T, Novak N: Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study. Clin Exp Dermatol. 2007; 37: 1277 – 1285.
161 Klein-Tebbe J, Fuchs T, Lepp U, Niggemann B, Saloga J, Vieluf I, Vieths S, Werfel T, Zuberbier T, Jäger L: In vitro diagnostics in food allergy: Position paper on the German Society of Allergy and Clinical Immunology (DGAKI) and the Society of German Allergologists (ÄDA). Laboratoriums Medizin. 2007; 31(59): 206 – 213.
160 Siebenhaar F, Kühn W, Zuberbier T, Maurer M: Successful treatment of cutaneous Mastocytosis with Anti-IgE. J Allergy Clin Immunol. 2007; 120(1): 213 – 215.
159 Magerl M, Schmolke J, Siebenhaar F, Zuberbier T, Metz M, Maurer M: Acquired cold urticaria symptoms can be safely prevents by ebastine. Allergy. 2007; 62(12): 1465 – 1468.
158 Zuberbier T: Nationale und internationale Infopoints für Fachpersonal und Patienten. Hautarzt. 2007; 58(4): 318 – 320.
157 Siebenhaar F, Syska W, Weller K, Magerl M, Zuberbier T, Metz M, Maurer M: Control of Pseudomonas aeruginosa Skin Infections in Mice is Mast Cell-Dependent. Am J Pathol. 2007; 170: 1910 – 1916.
156 Siebenhaar F, Weller K, Mlynek A, Magerl M, Altrichter S, Vieira Dos Santos R, Maurer M, Zuberbier T: Acquired cold urticaria: Clinical picture and update on diagnosis and treatment. Clin Exp Dermatol. 2007; 32(3): 241 – 245.
155 Zuberbier T, Heinzerling L, Bieber T, Schauer U, Klebs S, Bräutigam M: Steriod sparing effect of primecrolimus cream 1% in children with severe atopic dermatitis. Dermatology. 2007; 215: 325 – 330.
154 Maurer M, Zuberbier T: Undertreatment of Rhinitis Symptoms in Europe: findings from a cross-sectional questionnaire survey. Allergy. 2007; 62: 1057 – 1063.
153 Kurbacheva O, Zuberbier T: A visit to the mother in law - a hidden cause for urticaria. Allergy. 2007; 62(6): 711 – 712.
152 Zuberbier T, Maurer M: Urticaria: Current Opinions about Etiology, Diagnosis and Therapy. Acta Derm Venereol. 2007; 87: 196 – 205.
151 Oestmann E, Phillipp S, Zuberbier T, Worm M: Colophony induced contact dermatitis due to ECG electrodes in an infant. Contact Dermatitis. 2007; 56: 177 – 178.
150 Peiser M, Zuberbier T, Wanner R: Atopic skin is associated with a lack of phosphatidylcholine-sphingomyelin transacylase activity. J Invest Dermatol. 2007; 4: 973 – 975.
149 Vieths S, Holzhauser T, Erdmann S, Fuchs T, Henzgen M, Klein-Tebbe J, Lepp U, Niggemann B, Raithel M, Reese I, Saloga J, Vieluf I, Zuberbier T, Werfel T: Neue Deklarationspflicht für Nahrungsmittelallergene in Lebensmitteln. Allergologie. 2006; 29: 403 – 409.
148 Zuberbier T, Worm M: Allergies and the skin, an interdisciplinary approach in GA²LEN and EAACI activities. Allergy. 2006; 61: 1373 – 1376.
147 Niggemann B, Erdmann S, Fuchs T, Henzgen M, Jaeger L, Klein-Tebbe J, Lepp U, Raithel M, Reese I, Saloga J, Vieths S, Zuberbier T, Werfel T: Standardisierung von oralen Provokationstests bei Nahrungsmittelallergien. Allergologie. 2006; 29: 370-380.
146 Zuberbier T: Neue therapeutische Ansätze bei chronischer Urtikaria. MedReport. 2006; 30: 3 – 4.
145 Lee H.-H, Roediger C, Bauer A, Zuberbier T, Worm M: Prospective safety analysis of an ultrarush specific immunotherapy in adults with wasp venom allergy. Allergy. 2006; 10: 1237 – 1238.
144 Lee H.-H, Klein-Tebbe A, Zuberbier T, Worm M: Aktuelle Empfehlungen zur praktischen Durchführung von SCIT und SLIT. Hautarzt. 2006; 57: 860 – 866.
143 Reese I, Zuberbier T, Bunselmeyer B, Erdmann S, Henzgen M, Fuchs T, Jäger L, Klein-Tebbe J, Lepp U, Niggemann B, Raithel M, Saloga J, Viehts S, Werfel T: Diagnostisches Vorgehen bei Verdacht auf eine pseudoallergische Reaktion durch Nahrungsmittelinhaltstoffe. Leitlinie der Gesellschaft für Pädiatrische Allergologie u Umweltmedizin e.V. 2006.
142 Fiedler EM, Zuberbier T, Worm M: Atopische Dermatitis und Histaminintoleranz. Haut. 2006; 17: 62 – 64.
141 Stefaniak R, Zuberbier T: Epidemiologie der Urtikaria. Allergo J. 2006; 15: 196 – 198.
140 Zuberbier T, Przybilla B: Dem Geheimnis der Urtikaria auf der Spur [editorial]. Allergo J. 2006; 15: 169.
139 Cezmi A, Mübeccel A, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, Hamid Q, Kapp A, Leung D, Lipozencic J, Luger T, Muraro A, Novak N, Platts-Mills T, Rosenwasser L, Scheynius A, Simons E, Spergel J, Turjanmaa K, Wahn U, Weidinger S, Werfel T, Zuberbier T: Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology / American Academy of allergy, asthma and immunology / PRACTALL consenus report. Allergy. 2006; 61: 969 – 987.
138 Zuberbier T: State of the Art – Allergologie. Kompendium Dermatologie. 2006; 2 Jahrg., Nr. 1: 42 – 43.
137 Olze H, Forster U, Zuberbier T, Morawietz L, Luger EO: Eosinophilic nasal polyps are a rich source of Eotaxin, Eotaxin-2 and Eotaxin-3. Rhinology. 2006; 44: 145 – 150.
136 Niggemann B, Erdmann S, Fuchs T, Henzgen M, Jäger L, Klein-Tebbe J, Lepp U, Raithel M, Reese I, Saloga J, Vieluf I, Vieths S, Zuberbier T, Werfel T: Standardisierung von oralen Provokationstests bei Nahrungsmittelallergien. Allergo J. 2006; 15: 262 – 270.
135 Babina M, Rex C, Guhl S, Thienemann F, Artuc M, Henz B, Zuberbier T: Baseline and stimulated turnover of cell surface c-Kit expression in different types of human mast cells. Exp Dermatol. 2006; 15: 530 – 537.
134 Cezmi A, Mübeccel A, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, Hamid Q, Kapp A, Leung D, Lipozencic J, Luger T, Muraro A, Novak N, Platts-Mills T, Rosenwasser L, Scheynius A, Simons E, Spergel J, Turjanmaa K, Wahn U, Weidinger S, Werfel T, Zuberbier T: Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology / American Academy of allergy, asthma and immunology / PRACTALL consenus report. J Allergy Clin Immunol. 2006; 118: 152 – 169.
133 Worm M, Forschner K, Lee HH, Roehr CC, Edenharter G, Niggemann B, Zuberbier T: Frequency of atopic dermatitis and relevance of food allergy in adults in Germany. Acta Derm Venereol. 2006; 86: 119 – 122.
132 Heinzerling L, Worm M, Bergmann KC, Zuberbier T: Sublingual immunotherapy. J Dtsch Dermatol Ges. 2006; 4: 428 – 434.
131 Artuc M, Bohm M, Grutzkau A, Smorodchenko A, Zuberbier T, Luger T, Henz BM: Human mast cells in the Neurohormonal Network: Expression of POMC, Detection of Precursor Proteases and Evidence for IgE-dependent secretion of alpha-MSH. J Invest Dermatol. 2006; 126: 1976 – 1981.
130 Vieths S, Holzhauser T, Erdmann S, Fuchs T, Henzgen M, Klein-Tebbe J, Lepp U, Zuberbier T, Werfel T: Neue Deklarationspflicht für Nahrungsmittelallergene in Lebensmitteln. Allergo J. 2006; 15: 114 – 122.
129 Olze H, Förster U, Zuberbier T, Morawietz L, Luger EO: Eotaxin-, Eotaxin-2, Eotaxin-3- und RANTES-Proteinsynthese bei Polyposis nasi - Korrelation zu Eosinophilie und Ätiologie. Allergologie. 2006; 29: 77 – 85.
128 Zuberbier T: A review of recent journal highlights. Clin Exp Dermatol. 2006; 31: 499 – 500.
127 Zuberbier T, Orlow SJ, Paller A, Taieb A, Allen R, Hernanz Hermosa JM, Ocampo J, Cox M, Langeraar J, Simon J: Patient perspectives on the management of atopic dermatitis. J Clin Immunol. 2006; 118: 226 – 232.
126 Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CEH, Greaves MW, Henz BM, Kapp A, Kozel MMA, Maurer M, Merk HF, Schäfer T, Simon D, Vena G, Wedi B: EAACI/GA²LEN/EDF guideline: management of urticaria. Allergy. 2006; 61: 321 – 331.
125 Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CEH, Greaves MW, Henz BM, Kapp A, Kozel MMA, Maurer M, Merk HF, Schäfer T, Simon D, Vena G, Wedi B: EAACI/GA²LEN/EDF guideline: Definition, classification and diagnosis of urticaria. Allergy. 2006; 61: 316 – 320.
124 Lee H.-H, Landeck L, Stefaniak R, Zuberbier T, Worm M: Verträglichkeit der spezifischen Wespengift-Immuntherapie nach enem rush- oder ultra-rush-Protokoll: Eine prospektive vergleichende Untersuchung. Allergo J. 2005; 14: 482 – 486.
123 Henzgen M, Vieths S, Reese I, Erdmann S, Fuchs T, Jäger L, Klein-Tebbe J, Lepp U, Niggemann B, Saloga J, Vieluf I, Zuberbier T, Werfel T: Nahrungsmittelallergien durch immunologische Kreuzreaktionen. Allergo J. 2005; 14: 48 – 59.
122 Fiedler EM, Forschner K, Focke M, Hemmer W, Jarisch R, Zuberbier T, Worm M: Ernährung und Ekzemerkrankungen - Bedeutung von exogen zugeführtem Histamin bei Patienten mit atopischer Dermatitis. Dermatologie in Beruf und Umwelt. 2005; 53: 93 – 96.
121 Heinzerling L, Frew AJ, Bindslev-Jensen C, Bonini S, Bousquet J, Bresciani M, Carlsen KH, van Cauwenberge P, Darsow U, Fokkens WJ, Haahtela T, van Hoecke H, Jessberger B, Kowalski ML, Kopp T, Lahoz CN, Lodrup Carlsen KC, Papadopoulos NG, Ring J, Schmid-Gendelmeier P, Vignola AM, Wöhrl S, Zuberbier T: Standard skin prick testing and sensitization to inhalant allergens across Europe - a survey from the GA²LEN network. Allergy. 2005; 60: 1287 – 300.
120 Surrenti T, Sterry W, Zuberbier T: Urticaria. G Ital Dermatol Venereol. 2005; 140: 271 – 288.
119 Luger TA, Bieber T, Meurer M, Mrowitz U, Schwarz T, Simon J, Werfel T, Zuberbier T: Therapie des atopischen Ekzems mit Calcineurin-Inhibitoren. J Dtsch Dermatol Ges. 2005; 3: 385 – 391.
118 Welker P, Wanner R, Zuberbier T, Groeneberg DA, Henz BM: Gene expression and regulation of transcription factor activator protein-2 alpha in human mast cells. Allergy. 2005; 60: 1046 – 1052.
117 Van Cauwenberge P, Watelet JB, Van Zele T, Bousquet J, Burney P , Zuberbier T, GA²LEN partners: Spreading excellence in allergy and asthma: the GA²LEN (Global Allergy and Asthma European Network) project. Allergy. 2005; 60: 858 – 864.
116 Guhl S, Lee HH, Babina M, Henz BM, Zuberbier T: Evidence for a restricted rather than generalized stimulatory response of skin - derived human mast cells to substance P. J Neuroimmunol. 2005; 163: 92 – 101.
115 Guhl S, Stefaniak R, Strathmann M, Babina M, Henz BM, Zuberbier T: Bivalent effect of UV-light in human skin mast cells - low level mediator release at baseline but potent suppression upon mast cell triggering. J Invest Dermatol. 2005; 124: 453 – 456.
114 Babina M, Schulke Y, Kirchhof L, Guhl S, Franke R, Bohm S, Zuberbier T, Henz BM, Gombart AF: The transcription factor profile of human mast cells in comparison with monocytes and granulocytes. Cell Mol Life Sci. 2005; 62: 214 – 226.
113 Valent P, Arock M, Bischoff SC, Bühring HJ, Brockow K, Escribano L, Födinger M, Grabbe J, Hartmann K, Henz BM, Horny HP, Kluin-Nelemans HC, Lima M, Marone G, Orfao A, Parwaresch RM, Sillaber C, Sotlar K, Sperr WR, Triggiani M, Van Doormaal JJ, Wolff K, Zuberbier T: The European Competence Network on Mastocytosis (ECNM). Wien Klin Wochenschr. 2004; 116: 647 – 651.
112 Zuberbier T, Edenharter G, Worm M, Ehlers I, Reimann S, Hantke T, Roehr CC, Bergmann KE, Niggemann B: Prevalence of adverse reactions to food in Germany - a population study. Allergy. 2004; 59: 338 – 345.
111 Maurer M, Zuberbier T: Immer wieder Urtikaria. Leitlinien zur Diagnostik der chronischen Urtikaria. Der Deutsche Dermatologe. 2004; 52: 471 – 474.
110 Zuberbier T: Screeningverfahren für die Hautarztpraxis. Was kann der neue Allergie-Schnelltest? MMW Fortschr Med. 2004; 146: 16.
109 Khouw S, Zuberbier T: Die 10-Minuten-Sprechstunde: Urtikaria. MMW Fortschr Med. 2004; 46: 60 – 61.
108 Roehr CC, Edenharter G, Reimann S, Ehlers I, Worm M, Zuberbier T, Niggemann B: Food allergy and non-allergic food hypersensitivity in children and adolescents. Clin Exp Allergy. 2004; 34: 1534 – 41.
107 Buhner S, Reese I, Kuehl F, Lochs H, Zuberbier T: Pseudoallergic reactions in chronic urticaria are associated with altered gastroduodenal permeability. Allergy. 2004; 59: 1118 – 1123.
106 Haas N, Kuster W, Zuberbier T, Henz BM: Muckle-Wells syndrome: clinical and histological skin findings compatible with cold air urticaria in a large kindred. Br J Dermatol. 2004; 151: 99 – 104.
105 Asero R, Lorini M, Chong SU, Zuberbier T, Tedeschi A: Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells. Clin Exp Allergy. 2004; 34: 1111 – 1114.
104 Babina M, Guhl S, Kirchhof L, Zuberbier T, Henz BM: Comparative cytokine profile of human skin mast cells from two compartments - strong resemblance with monocytes at baseline, but induction of selective Th2 mediators by IL-4 priming. J Leukoc Biol. 2004; 75: 244 – 252.
103 Bousquet J, Ansotegui IJ, Ree RV, Burney P, Zuberbier T, Cauwenberge PV: European Union meets the challenge of the growing importance of allergy and asthma in Europe. Allergy. 2004; 59: 1 – 4.
102 Zuberbier T, Edenharter G, Worm M, Ehlers I, Reimann S, Hantke T, Roehr CC, Bergmann KE, Niggemann B: Prevalance of adverse reactions to food in Germany - a population study. Allergy. 2004; 59: 338 – 345.
101 Guhl S, Hartmann K, Tapkenhinrichs S, Smorodchenko A, Grützkau A, Henz BM, Zuberbier T: Ultraviolet irradiation induces apoptosis in human immature, but not in skin mast cells. J Invest Dermatol. 2003; 121: 837 – 844.
100 Zuberbier T: Urticaria. Allergy. 2003; 58: 1224 – 1234.
99 Röver A, Heine G, Zuberbier T, Worm M: Allergen-mediated modulationof CD23 expression is IFN-? and IL-10 dependent in allergic and non-allergic individuals. Clin Exp Allergy. 2003; 33: 1568 – 1575.
98 Zuberbier T: Allergie-Diagnostik. Z. ärztl. Fortbild. Qual. sich. 2003; 97: 446 – 451.
97 Zuberbier T, Aberer W, Grabbe J, Hartmann K, Merk H, Ollert M, Rueff F, Wedi B, Wenning J: Diagnostik und Therapie der Urtikaria (DDG-Leitlinie). J Dtsch Dermatol Ges. 2003; 8: 655 – 664.
96 Forschner K, Zuberbier T, Worm M: Benzyolperoxid als Ursache einer Airborne-Kontaktdermatitis bei einem Orthopädiemechaniker. Aktuelle Derm. 2003; 29: 195 – 196.
95 Forschner K, Klein-Tebbe A, Zuberbier T, Worm M: Type I sensitization towards patent blue as a cause of anaphylaxis. Allergy. 2003; 58: 457 – 458.
94 Hermes B, Zuberbier T, Haas N, Henz BM: Decreased cutaneous expression of stem cell factor and of the p75NGF receptor in urticaria. Br J Dermatol. 2003; 148: 411 – 417.
93 Werfel T, Fuchs T, Reese I, Erdmann S, Henzgen M, Klein-Tebbe J, Lepp U, Niggemann B, Saloga J, Vieluf I, Vieths S, Zuberbier T: Vorgehen bei vermuteter Nahrungsmittelallergie bei atopischer Dermatitis. Allergologie. 2003; 26: 33 – 41.
92 Röver AC, Reimann S, Zuberbier T, Worm M: Immunophenotypic characterization of peripheral B cells during short-term immunotherapy tree pollen allergoid and the immunoadjuvant monophosporyl lipid A. J Invest Allergol Clin Immunol. 2002; 12: 227 – 234.
91 Forschner K, Zuberbier T, Worm M: Benzoyl peroxide as a cause of airborne contact dermatitis in an orthopaedic technician. Contact Dermatitis. 2002; 47: 241.
90 Fiedler EM, Zuberbier T, Worm M: A combination of wheat flour, ethanol and food additives inducing FDEIA. Allergy. 2002; 57: 1090 – 1091.
89 Lepp US, Erdmann S, Fuchs T, Henzgen M, Klein-Tebbe J, Niggemann B, Saloga J, Vieluf I, Vieths S, Zuberbier T, Werfel T: Therapiemöglichkeiten bei der IgE-vermittelten Nahrungsmittel-Allergie. Allergologie. 2002; 25: 585 – 590.
88 Chong SU, Worm M, Sterry W, Zuberbier T: Role of adverse reactions to food in urticaria and exercise-induced anaphylaxis. Int Arch Allergy Immunol. 2002; 129: 19 – 26.
87 Ehlers I, Hipler UC, Zuberbier T, Worm M: Ethanol as a cause of hypersensitivity reactions to alcoholic beverages. Clin Exp Allergy. 2002; 32: 1231 – 1235.
86 Gellrich S, Zuberbier T: Ergänzungen und Korrekturen zum Weiterbildungsbeitrag "Innenraumallergene". Hautarzt. 2002; 53: 292 – 293.
85 Klein-Tebbe J, Fuchs T, Lepp U, Niggemann B, Saloga J, Vieluf I, Vieths S, Werfel T, Zuberbier T, Jäger L: In-vitro-Diagnostik von Nahrungsmittelallergien. Allergologie. 2002; 25: 341 – 349 (Erstdruck: Allergo J 2001; 10: 333 – 339).
84 Lepp US, Erdmann S, Fuchs T, Henzgen M, Klein-Tebbe J, Niggemann B, Saloga J, Vieluf I, Vieths S, Zuberbier T, Werfel T: Therapiemöglichkeiten bei der IgE-vermittelten Nahrungsmittel-Allergie. Allergo J. 2002; 11: 156 – 162.
83 Meyer L, Zuberbier T, Worm M, Oettle H, Riess H: Hypersensitivity reactions to oxaliplatin: crossreactivity to carboplatin and the introduction of a desensitization schedule. J Clin Oncology. 2002; 20: 1146 – 1147.
82 Zuberbier T, Pfrommer C, Specht K, Vieths S, Bastl-Borrmann R, Worm M, Henz BM: Aromatic components of food as novel eliciting factors of pseudoallergic reactions in chronic urticaria. J Allergy Clin Immunol. 2002; 109: 348 – 349.
81 Ehlers I, Forschner K, Zuberbier T, Sterry W, Worm M: Ernährungsstatus bei erwachsenen Patienten mit atopischer Dermatitis. Hautarzt. 2002; 53: 183 – 188.
80 Zuberbier T: The role of allergens and pseudoallergens in urticaria. J Invest Dermatol Symp Proc. 2001; 6: 132 – 134.
79 Zuberbier T, Greaves MW, Juhlin L, Merk H, Stingl G, Henz BM: Management of urticaria - a consensus report. J Invest Dermatol Symp Proc. 2001; 6: 128 – 131.
78 Zuberbier T, Greaves MW, Juhlin L, Kobza-Black A, Maurer D, Stingl G, Henz BM: Definition, classification and routine diagnosis of urticaria - a consensus report. J Invest Dermatol Symp Proc. 2001; 6: 123 – 127.
77 Klein-Tebbe J, Lepp U, Niggemann B, Saloga J, Vieluf I, Werfel T, Zuberbier T, Jäger L: In-vitro-Diagnostik von Nahrungsmittelallergien. Allergo J. 2001; 10: 333 – 339.
76 Zuberbier T: Pseudoallergene und chronische Urtikaria. Allergologie. 2001; 24: 457 – 462.
75 Ehlers I, Worm M, Sterry W, Zuberbier T: Sugar is not an aggravating factor in atopic dermatitis. Acta Derm Venereol. 2001; 81: 282 – 284.
74 Gellrich S, Zuberbier T: Innenraumallergene. Hautarzt. 2001; 52: 915 – 924.
73 Zuberbier T, Welker P, Henz BM: Effect of granulocyte macrophage colony-stimulating factor in a patient with benign systemic mastocytosis. Br J Dermatol. 2001; 145: 661 – 666.
72 Zuberbier T, Chong SU, Grunow K, Guhl S, Welker P, Grassberger M, Henz BM: The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils. J Allergy Clin Immunol. 2001; 108: 275 – 280.
71 Vieths S, Meyer AH, Ehlers I, Fuchs T, Klein-Tebbe J, Lepp U, Niggemann B, Saloga J, Sennekamp J, Vieluf I, Werfel T, Zuberbier T, Jäger L: Zur Deklaration "versteckter Allergene" in Lebensmitteln. Allergologie. 2001; 24: 316 – 9.
70 Welker P, Grabbe J, Zuberbier T, Grützkau A, Henz BM: GM-CSF downregulates c-Kit, FceRIa and receptor expression as well as histamine and tryptase levels in cultured human mast cells. Archives of Dermatological Research. 2001; 293: 249 – 258.
69 Zuberbier T, Lelke A, Sänger A, Welker P, Guhl S, Henz BM: Comparison of mast cell precursors and cultured mast sells from the blood of children with atopic and nonatopic parents. Int Arch Allergy Immunol. 2001; 124: 304 – 6.
68 Henz BM, Zuberbier T: Schlusswort: Unterschiede in den Kollektiven der chronischen Urtikaria als Erklärung abweichender Ergebnisse bei der Ursachensuche (Brief). Hautarzt. 2001; 52: 253 – 4.
67 Schimmelpfennig C, Naumann R, Zuberbier T, Ordemann R, Baurmann H, Beyer J, Siegert W, Bornhäuser M, Ehninger G: Skin involvement as the first manifestation of systemic aspergillosis in patients after allogeneic hematopoietic cell transplantation. Bone Marrow Transpl. 2001; 27: 753 – 5.
66 Worm M, Vieth W, Ehlers I, Sterry W, Zuberbier T: Increased leukotriene production by food additives in patients with atopic dermatitis and proven food intolerance. Clin Exp Allergy. 2001; 31: 265 – 273.
65 Hermes B, Welker P, Feldmann-Böddeker I, Krüger-Krasagakes S, Hartmann K, Zuberbier T, Henz BM: Expression of mast cell growth modulating and chemotactic factors and their receptors in human cutaneous scars. J Invest Dermatol. 2001; 116: 387 – 393.
64 Welker P, Grabbe J, Gibbs B, Zuberbier T, Henz BM: Nerve growth facor-beta induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells. Immunology. 2000; 99: 418 – 23.
63 Worm M, Sterry W, Zuberbier T: Gelatin-induced urticaria and anaphylaxis after tick-borne encephalitis vaccine (letter). Acta Derm Venereol. 2000; 80: 232.
62 Zuberbier T, Witt C: Nahrungsmittelunverträglichkeitsreaktionen als Auslöser von Asthma. Atemw Lungenkrkh. 2000; 6: 303 – 307.
61 Zuberbier T, Henz BM, Fiebiger E, Maurer D, Stingl G: Anti-FceRIa serum autoantibodies in different subtypes of urticaria. Allergy. 2000; 55: 951 – 954.
60 Worm M, Ehlers I, Sterry W, Zuberbier T: Clinical relevance of food additives in adult patients with atopic dermatitis. Clin Exp Allergy. 2000; 30: 407 – 414.
59 Henz BM, Zuberbier T: Urtikaria - Neue Entwicklungen und Perspektiven. Hautarzt. 2000; 51: 302 – 308.
58 Reimann S, Worm M, Sterry W, Zuberbier T: Pollenassoziierte Nahrungsmittelallergien - Orales Allergie-Syndrom. Zeitschrift für Hautkrankheiten H+G. 2000; 75: 8 – 15.
57 Ehlers I, Zuberbier T: Lücken und Tücken der Kennzeichnungs-Verordnung. Aktuelle Derm. 2000; 26: 32 – 34.
56 Worm M, Ehlers I, Zuberbier T: Rolle pseudoallergischer Nahrungsmittelunverträglichkeiten in der Dermatologie. Aktuelle Derm. 2000; 26: 15 – 18.
55 Esen M, Zuberbier T: Nahrungsmittelunverträglichkeiten: Übersicht und Prävelenz. Aktuelle Derm. 2000; 26: 7 – 9.
54 Welker P, Grabbe J, Zuberbier T, Guhl S, Henz BM: Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells. J Invest Dermatol. 2000; 114: 44 – 50.
53 Zuberbier T, Henz BM: Use of cetirizine in dermatologic disorders. Ann Allergy Asthma Immunol. 1999; 83: 476 – 480.
52 Zuberbier T, Guhl S, Hantke T, Hantke C, Welker P, Grabbe J, Henz BM: Alterations in ganglioside expression during the differentiation of human mast cells. Exp Dermatol. 1999; 8: 380 – 387.
51 Zuberbier T, Khreis I, Guhl S, Mrowietz U: Tannin inhibits histamine release. Allergy. 1999; 54: 898 – 900.
50 Werfel T, Wedi B, Klein-Tebbe J, Niggemann B, Saloga J, Sennekamp J, Vieluf I, Vieths S, Zuberbier T, Jäger L: Vorgehen bei Verdacht auf eine pseudoallergische Reaktion auf Nahrungsmittelinhaltsstoffe. Allergo J. 1999; 4: 135 – 141.
49 Hein UR, Chantraine-Hess S, Worm M, Zuberbier T, Henz BM: Evaluation of systemic provocation tests in patients with suspected allergic and pseudoallergic drug reactions. Acta Derm Venereol. 1999; 79: 139 – 142.
48 Welker P, Grabbe J, Gibbs B, Zuberbier T, Henz BM: Human mast cells produce and differentially express both soluble and membrane-bound stem cell factor. Scand J Immunol. 1999; 49: 495 – 500.
47 Welker P, Grabbe J, Zuberbier T, Henz BM: IgE downmodulates SCF-driven mast cell development from cultured peripheral blood mononuclear cells. Int Arch Allergy Immunol. 1999; 118: 292 – 293.
46 Zuberbier T: Pseudoallergy or nonallergic hypersensitivity (letter). Allergy. 1999; 54: 397 – 398.
45 Zuberbier T: Nahrungsmittel-Allergien und Pseudo-Allergien: Praktisches Vorgehen in der Diagnostik und Therapie. Was ist sinnvoll, worauf kann verzichtet werden? Aktuelle Berliner Fortbildungsreihe. 1998; 14: 43 – 47.
44 Lippert U, Artuc M, Grützkau A, Möller A, Kenderessy-Szabo A, Schadendorf D, Norgauer J, Hartmann K, Schweitzer-Stenner R, Zuberbier T, Henz BM, Krüger-Krasagakes S: Expression and functional activity of the IL-8 receptor type CXCR1 on human mast cells. J Immunol. 1998; 161: 2600 – 2608.
43 Henz BM, Zuberbier T: Most chronic urticaria is food-dependent and not idiopathic. Exp Dermatol. 1998; 7: 139 – 142.
42 Ehlers I, Niggemann B, Binder C, Zuberbier T: Role of non-allergic hypersensitivity reactions in children with chronic urticaria. Allergy. 1998; 53: 1074 – 1077.
41 Zuberbier T: Stellenwert von Nahrungsmittelzusatzstoffen: Fakt oder Mythos? Allergo J. 1998; 7: SA32 – 36.
40 Worm M, Jeep S, Sterry W, Zuberbier T: Perioral contact dermatitis caused by L-carvone in toothpaste. Contact Dermatitis. 1998; 38: 338.
39 Zwirner J, Götze O, Siebers A, Kapp A, Begemann G, Zuberbier T, Werfel T: The human mast cell line HMC-1 binds and responds to C3a but not C3a(desArg). Scand J Immunol. 1998; 47: 19 – 24.
38 Grabbe J, Welker P, Grützkau A, Dippel E, Nürnberg W, Zuberbier T, Henz BM: Induction of human leukaemic mast cell differentiation by fibroblast supernatants, but not by stem cell factor. Scand J Immunol. 1998; 47: 324 – 331.
37 Henz BM, Metzenauer P, O´Keefe E, Zuberbier T: Differential effects of new generation H1-receptor antagonists in pruritic dermatoses. Allergy. 1998; 53: 180 – 183.
36 Welker P, Grabbe J, Zuberbier T, Henz BM: GM-CSF downregulates mast cell specific tryptase, FceRI and histamine. Int Arch Allergy Immunol. 1997; 113: 284 – 286.
35 Zuberbier T, Henz BM: Urtikarielle Hautreaktionen auf Aspirin. Allergologie. 1997; 12: 620 – 625.
34 Zuberbier T, Schadendorf D, Haas N, Hartmann K, Henz BM: Enhanced P-selectin expression in chronic and dermographic urticaria. Int Arch Allergy Immunol. 1997; 114: 86 – 89.
33 Vieths S, Bastl R, Pfrommer C, Zuberbier T: Lebensmittelallergien und andere Unverträglichkeiten gegen Lebensmittelinhaltsstoffe. Naturw Rdsch. 1997; 8: 303 – 310.
32 v. Stebut E, Maurer M, Zuberbier T: Intoleranzreaktionen auf systemische Kortikosteroide. Allergologie. 1997; 7: 336 – 339.
31 Hartmann K, Henz BM, Krüger-Krasagakes S, Köhl J, Burger R, Haase I, Lippert U, Zuberbier T: C3a and C5a stimulate chemotaxis of human mast cells. Blood. 1997; 89: 2863 – 2870.
30 Niggemann B, Zuberbier T, Herz U, Enssle K, Wahn U, Renz H: Interleukin-4 (IL-4) enhances and soluble interleukin-4 receptor (sIL-4R) inhibits histamine release from peripheral blood basophils and mast cells in vitro and in vivo. Mediators Inflamm. 1997; 6: 111 – 118.
29 Zuberbier T, Henz BM: Pseudoallergen-free diet in the treatment of chronic urticaria (letter). Acta Derm Venereol. 1996; 76: 499.
28 Weber S, Krüger-Krasagakes S, Grabbe J, Zuberbier T, Czarnetzki BM: Mast cells in scars and granulomatous reactions (letter). Int J Dermatol. 1996; 35: 607.
27 Zuberbier T, Münzberger C, Haustein U, Trippas E, Burtin B, Mariz SD, Henz BM: Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. Dermatology. 1996; 193: 324 – 327.
26 Zuberbier T, Iffländer J, Semmler C, Czarnetzki BM: Acute urticaria - clinical aspects and therapeutical responsiveness. Acta Derm Venereol. 1996; 76: 295 – 297.
25 Jankiewicz A, Aulepp H, Baltes W, Bögl KW, Dehne LI, Zuberbier T, Vieths S: Allergic sensitization to native and heated celery root in pollen-sensitive patients investigated by skin test and IgE binding. Int Arch Allergy Immunol. 1996; 111: 268 – 278.
24 Möller A, Henning M, Zuberbier T, Czarnetzki-Henz BM: Epidemiologie und Klinik der Kälteurtikaria. Hautarzt. 1996; 47: 510 – 514.
23 Ehlers I, Henz BM, Zuberbier T: Diagnose und Therapie pseudoallergischer Reaktionen der Haut auf Nahrungsmittel. Allergologie. 1996; 6: 270 – 276.
22 Schadendorf D, Diehl S, Zuberbier T, Kohlmus C, Czarnetzki BM: Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage. Dermatology. 1996; 192: 89 – 93.
21 Zuberbier T, Czarnetzki BM: High response rate to additive-free diet in chronic urticaria (letter). Br J Dermatol. 1996; 134: 1159.
20 Zuberbier T, Schwarz S, Hartmann K, Czarnetzki BM: Histamine releasability of basophils and skin mast cells in patients with chronic urticaria. Allergy. 1996; 51: 24 – 28.
19 Zuberbier T, Czarnetzki BM: Is there a place for systemic corticosteroids in urticaria? Ann Derm Venereol. 1995; 122: 737.
18 Zuberbier T, Chantraine-Hess S, Hartmann K, Czarnetzki BM. Pseudoallergen-free diet in the treatment of chronic urticaria - a prospective study. Acta Derm Venereol. 1995; 75: 484 – 487.
17 Möller A, Zuberbier T, Chantraine-Hess S, Henz BM: Bedeutung der Focussuche für die Urtikaria-Diagnostik. Allergologie. 1995; 18: 547 – 551.
16 Hartmann K, Beiglböck F, Czarnetzki BM, Zuberbier T: Effect of CC chemokines on mediator release from human skin mast cells and basophils. Int Arch Allergy Immunol. 1995; 108: 224 – 230.
15 Zuberbier T, Pfrommer C, Beinhölzl J, Hartmann K, Czarnetzki BM: Gangliosides enhance IgE receptor-dependent histamine and LTC4 release from human mast cells. Biochim Biophys Acta. 1995; 1269: 79 – 84.
14 Schadendorf D, Zuberbier T, Diehl S, Kohlmus C, Czarnetzki BM: Serum manganese superoxide dismutase is a new tumor marker for malignant melanoma. Melanoma Res. 1995; 5: 351 – 353.
13 Czarnetzki BM, Grabbe J, Kolde G, Krüger-Krasagakes S, Zuberbier T: Mast cells in the cytokine network - the what, where from and what for. Exp Dermatol. 1995; 4: 221 – 226.
12 Weber S, Krüger-Krasagakes S, Grabbe J, Zuberbier T, Czarnetzki BM: Mast cells. Int J Dermatol. 1995; 14: 1 – 10.
11 Zuberbier T, Czarnetzki BM: Urtikaria - aktuelle Aspekte der Diagnostik und Therapie. Der Deutsche Dermatologe. 1995; 43: 148 – 153.
10 Zuberbier T, Aberer W, Burtin B, Rihoux J-P, Czarnetzki BM: Efficacy of cetirizine in cholinergic urticaria. Acta Derm Venereol . 1995; 75: 147 – 149.
9 Zuberbier T, Althaus C, Chantraine-Hess S, Czarnetzki BM: Prevalence of cholinergic urticaria in young adults. J Am Acad Dermatol. 1994; 31: 978 – 981.
8 Hermes B, Haas N, Zuberbier T, Czarnetzki BM: Metastasierender extramammärer M.Paget. Hautarzt. 1994; 69: 351.
7 Zuberbier T: Nahrungsmittel und Streß - Bedeutung für die Ätiologie der Urtikaria. Allergologie. 1994; 17 (4): 6-8.
6 Lichey J, Zuberbier T, Luck W, Lau S, Wahn U: Influence of glycosphingolipids on the release of histamine and sulfidopeptide leukotrienes from human basophils. Int Arch Allergy Immunol. 1994; 103: 252 – 259.
5 Grabbe J, Möller A, Welker P, Zuberbier T, Dippel E, Weber S, Rosenbach T, Krüger-Krasagakes S, Haas N, Czarnetzki BM: Basophile und Mastzellen. Atemw Lungenkrkh. 1993; 7: 280 – 283.
4 Grabbe J, Zuberbier T, Wagenpfeil S, Czarnetzki BM. Skin prick tests to common allergens in adult atopic eczema and rhinitis patients: reproducibility on duplicate and repeated testing. Dermatology. 1993; 186:113-117.
3 Zuberbier T, Böhm M, Czarnetzki BM: Food intake in combination with a rise in body temperature: a newly identified cause of angiodema. J Allergy Clin Immunol 1993; 91: 1226 – 1227.
2 Zuberbier T, Czarnetzki BM. Nahrungsmittelunverträglichkeit (II). Hautarzt. 1993; 44:57-62.
1 Zuberbier T, Czarnetzki BM. Nahrungsmittelunverträglichkeit (I). Hautarzt. 1992; 43:805-811.

Prof. Dr. med. Dr. h.c. Torsten Zuberbier

Leiter des Allergie-Centrum-Charité – Standort Hautklinik
Sprecher des Comprehensive Allergy Center Charité

Allergie-Centrum-Charité
Charité - Universitätsmedizin Berlin

Charitéplatz 1
D - 10117 Berlin

Tel.: +49 30 450 518 135
E-Mail: torsten.zuberbier(at)charite.de

Prof. Dr. Zuberbier im www: